Sommaire

• • ·Title Page

    Page :i

    

• Abstracts for the ‘Cardiac Society of Australia and New Zealand Annual Scientific Meeting and the International Society for Heart Research Australasian Section Annual Scientific Meeting' 13-16 August 2015

  • ·Near infra-red autofluorescence of intraplaque haemorrhage: a novel discovery facilitating identification of vulnerable plaques

    Page :S113

    N. Htun, Y. Chen, H. Schneider, K. Peter

    
  • ·Androgens ameliorate age-related impairment in ischaemia-induced neovascularisation by enhancing vasculogenesis

    Page :S113

    Y. Lam, L. Leece, S. Yuen, D. Handelsman, R. Karas, M. Ng

    
  • ·Fenofibrate rescues diabetes-related impairment of ischaemia-mediated angiogenesis by a PPAR? independent pathway

    Page :S114

    J. Yuan, K. Rajamani, E. King, C. Bursill, L. Lecce, A. Jenkins, A. Keech, M. Ng

    
  • ·Progression of atrial remodelling in patients with high burden AF: implications for early ablative intervention

    Page :S114

    T. Walters, A. Nisbet, G. Morris, G. Tan, M. Mearns, J. Morton, S. Joseph, G. Lee, P. Kistler, J. Kalman

    
  • ·Colchicine markedly suppresses trans-coronary and cellular release of inflammasome-derived cytokines in Acute Coronary Syndrome (ACS) patients

    Page :S115

    S. Robertson, G. Martinez, C. Payet, J. Barraclough, D. Celermajer, C. Bursill, S. Patel

    
  • ·Aggressive Risk factor REduction STudy: implications for the substrate for Atrial Fibrillation (ARREST-AF Substrate Study)

    Page :S115

    R. Pathak, M. Middeldorp, M. Meredith, S. Stolcman, S. Willoughby, R. Mahajan, D. Twomey, K. Roberts-Thomson, D. Lau, W. Abhayaratna, P. Sanders

    
  • ·Prediction of 30-day heart failure readmissions and death

    Page :S116

    Q. Huynh, K. Negishi, T. Marwick

    
  • ·Radiation exposure to trans-oesophageal echocardiograhpy operators during structural intervention

    Page :S117

    J. Crowhurst, M. Whitby, D. Murdoch, B. Robinson, G. Scalia, D. Walters

    
  • ·Sternal micromotion during upper limb movements: Is it time for a change to sternal precautions following cardiac surgery via a median sternotomy?

    Page :S117

    S. Balachandran, L. Denehy, A. Lee, A. Royse, D. El-Ansary

    
  • ·Epidemiological analysis of a cohort of rural and remote STEMI patients in NSW

    Page :S118

    S. Faddy, M. McMullen, P. Stewart

    
  • ·Do cardiac rehabilitation programs offer cardiopulmonary resuscitation training in Australia and New Zealand?

    Page :S118

    S. Cartledge, J. Bray, J. Finn

    
  • ·Electronic chest pain pathway (eCPP)

    Page :S118

    A. Tiberio, A. Brown, A. Lee, G. Femia, T. Fetahovic

    
  • ·Temporal changes in patient's clinical profile entering into a comprehensive outpatient cardiac rehabilitation program.

    Page :S119

    R. Zecchin, J. Baihn, Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, C. Chow, D. Ross, R. Denniss

    
  • ·Coronary heart disease in Chinese living in western countries: new insights from a systematic review and meta-analysis

    Page :S119

    K. Jin, D. Ding, J. Gullick, F. Koo, L. Neubeck

    
  • ·Effects of fenofibrate on hypoxia tolerance in diabetes and associated molecular mechanisms

    Page :S119

    S. Chen, E. King, J. Yuan, A. Jenkins, A. Keech, M. Ng

    
  • ·Cardiac fibrosis and ?₂-adrenergic activation contribute to spontaneous ventricular tachyarrhythmias in a transgenic model

    Page :S120

    M. Nguyen, H. Kiriazis, D. Ruggiero, X. Gao, Y. Su, L. Han, A. Jian, J. McMullen, X. Du

    
  • ·Arrhythmic vulnerability in primary cardiac hypertrophy is associated with augmented CaMKII/PKA signaling

    Page :S120

    A. Raaijmakers, C. Curl, W. Ip, L. Delbridge, J. Bell

    
  • ·Differential cardiac expression of individual lipids in the plasmalogen biosynthetic pathway in response to pressure overload in mice

    Page :S121

    Y. Tham, J. Ooi, N. Mellett, X. Gao, K. Huynh, P. Meikle, J. McMullen

    
  • ·A case of obstructive sleep apnoea presented with hypertensive emergency

    Page :S121

    S. Silaruks, K. Sawanyawisuth

    
  • ·A comparison of the angiogenic properties of induced endothelial cells and induced pluripotent stem cell derived endothelial cells in a murine hindlimb ischaemia model

    Page :S122

    Z. Clayton, G. Yuen, S. Sadeghipour, S. Abraham, J. Wong, J. Hywood, J. Cooke, S. Patel

    
  • ·An increase in peak excess pressure accounts for the rise in systolic blood pressure along the aorta

    Page :S122

    O. Narayan, J. Davies, A. Hughes, K. Parker, S. Hope, I. Meredith, J. Cameron

    
  • ·Central blood pressure can be validly assessed from radial pulse waveforms in growing children – a longitudinal study

    Page :S123

    Y. Cai, X. Cai, A. Qasem, C. Melki, M. Butlin, J. Ayer, S. O’Meagher, B. Toelle, G. Marks, A. Alvolio, D. Celermajer, M. Skilton

    
  • ·Central blood pressure measurement in children - development and validation of a paediatric transfer function

    Page :S124

    Y. Cai, A. Qasem, C. Melki, M. Butlin, J. Ayer, J. Harmer, B. Toelle, G. Mark, A. Alvolio, D. Celermajer, M. Skilton

    
  • ·Discrimination of cardiac structural abnormalities from central blood pressure: mean arterial pressure provides the optimal calibration

    Page :S124

    K. Negishi, H. Yang, Y. Wang, M. Nolan, M. Saito, T. Negishi, J. Sharman, T. Marwick

    
  • ·Does exercise-induced hypertension reliably predict established hypertension?

    Page :S125

    M. Dwan, G. King, T. Forshaw, R. Pascoe, V. Manins

    
  • ·Ealry experience of Renal artery denervation for resistant hypertension using a Multi-Electrode catheter

    Page :S125

    W. Ahmad, S. Thambar, M. Chaplin

    
  • ·Effects of dobutamine and glyceryl trinitrate therapy on coronary blood flow, the coronary wave intensity profile and central aortic pressure waveform

    Page :S125

    O. Narayan, M. Leung, D. Wong, Y. Malaiapan, I. Meredith, J. Cameron

    
  • ·Index

    Page :S126

    
  • ·Experimental study on anti-atherosclerosis effect of 2 new ADP-receptor antagonists: prasugrel and ticagrelor

    Page :S126

    J. Cao, L. Fan, G. Hu, W. Len, T. Chen, L. Liu

    
  • ·Hypertension in aortic stenosis: a systematic review

    Page :S127

    M. Sharma, M. Eskandari, T. Marwick

    
  • ·Initial experience with macitentan in contemporary patient cohort

    Page :S127

    A. Khan, N. Collins, G. Reeves, B. Bastian, S. Dunlap

    
  • ·Interrupting prolonged sitting reduces resting blood pressure in adults with type 2 diabetes

    Page :S127

    P. Dempsey, J. Sacre, N. Owen, N. Straznicky, N. Cohen, B. Kingwell, D. Dunstan

    
  • ·Low cardiovascular risk subjects are more susceptible to microvascular dysfunction from bushfire air pollution

    Page :S128

    K. Negishi, E. Jalil, M. Lankaputhra, M. Mazhar, M. Dennekamp, F. Johnston

    
  • ·National Heart Foundation hypertension guideline update - 2015

    Page :S128

    T. Medley, J. Wilson

    
  • ·Percutaneous isolated limb perfusion delivery of antibiotic to the lower limb

    Page :S129

    M. Byrne, P. Wraight, S. Christov, J. McCann, R. Dowling, P. Mitchell, D. Kaye

    
  • ·Primary hypoplasia of aortic arch - an unrecognised cause of hypertension in the juvenile

    Page :S129

    K. Goh, T. Goh, T. Goh, E. Goh, Y. Willis, C. Chan

    
  • ·Renal denervation reduces monocyte activation in human hypertension

    Page :S129

    M. Zaldivia, J. Rivera, P. Marusic, D. McCartney, R. Lee, N. Htun, U. Flierl, J. Duval, L. Hammond, M. Schlaich, K. Peter

    
  • ·Telomere length in early childhood predicts carotid intima-media thickness in adolescence - the CardioCAPS study

    Page :S130

    J. Barraclough, M. Skilton, S. Nakhla, B. Toelle, G. Marks, D. Celermajer

    
  • ·Timing of the carotid pressure wave inflection point is coupled to systolic myocardial motion

    Page :S130

    O. Narayan, Q. Li, P. Mottram, I. Meredith, J. Cameron

    
  • ·Use of flow mediated dilatation to assess endothelial function in a female cohort of mixed ancestry in Cape Town, South Africa

    Page :S131

    I. Webster, H. Strijdom, C. Westcott, C. Marincowitz, N. Goswami, P. De Boever, T. Nawrot

    
  • ·Wave intensity vs. mid-systolic flow notching as indicators of microvascular disease in pulmonary hypertension

    Page :S131

    R. Swain, J. Mynard

    
  • ·20th Century methods in 2015 – time to re-look?

    Page :S132

    I. Ternouth, J. Downie

    
  • ·A large single centre case series of spontaneous coronary artery dissection

    Page :S132

    J. Antony, C. Raffel, K. Poon

    
  • ·A novel therapeutic target in ACS

    Page :S132

    S. Mylabathula, R. Harjit Singh, J. Lim, D. Cook

    
  • ·A rare case of concurrent transient global amnesia and transient left ventricular dysfunction

    Page :S133

    P. Jain, J. Michel, J. McCrohon

    
  • ·A rare cause of acute coronary syndrome in a young person, treated with non-coronary intervention

    Page :S133

    T. Pasley, J. Sood, A. To, T. Elliot, R. Bera, G. Armstrong, J. Bottomly

    
  • ·A success story of pre-hospital thrombolysis in remote Victoria: Lessons from a unique collaboration between health care providers. A case report

    Page :S133

    E. Sinclair, T. Hogue, P. Meddings, K. Murdoch

    
  • ·A tale of two receptors - Investigating how adenosine A2 receptors modulate adenosine A1 receptor-mediated cardioprotection

    Page :S134

    E. Vecchio, A. TN Nguyen, C. Tan, P. White, L. May

    
  • ·An audit of inter-hospital patient transfers for coronary angiography from a rural centre in Australia

    Page :S134

    J. Janardan, K. Haji, A. Al Alawi, D. Wong, H. Gibbs, A. Soward

    
  • ·An audit of local total ischaemic times and factors influencing delay in symptom onset to medical attention in patients with STEMI

    Page :S135

    D. Russell, P. Roberts-Thomson

    
  • ·An untargeted proteomic study identifies proteins associated with post-procedural myocardial infarction

    Page :S135

    C. Judkins, S. Palmer, P. Williams, I. Cooke, J. Garlic, R. Whitbourn, A. Wilson

    
  • ·Angina outcomes in Australian patients undergoing intracoronary acetylcholine provocation testing

    Page :S135

    D. Di Fiore, C. Zeitz, A. Sheikh, J. Beltrame

    
  • ·Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA): classical imaging findings on angiography and echocardiography

    Page :S136

    A. Ihdayhid, S. Chopra, M. Erickson

    
  • ·Antiplatelet therapy in the very elderly: should tolerability of therapy after percutaneous coronary intervention guide patient and device selection?

    Page :S136

    M. Allan, S. Ong, S. Roy, P. Gonski, M. Pitney

    
  • ·Assessment of junior medical staff's ability to diagnose ST Elevation Myocardial Infarction (STEMI) on ECG in a level 3 teaching hospital in Australia

    Page :S137

    A. Khan, I. Agahari, A. Ashraf, J. Attia

    
  • ·Association between post-operative mean arterial pressure and perioperative troponin rise in elderly patients undergoing surgical repair for neck of femur fractures

    Page :S137

    E. Khan, M. Loh

    
  • ·Audit of non-transmural acute coronary syndrome protocols

    Page :S138

    G. Gan, A. Bhat, Y. Kuang, D. Burgess, A. Denniss

    
  • ·Australian trends in the investigation of coronary artery disease (CAD)

    Page :S138

    P. Ngu, V. Mutha, R. Harper

    
  • ·Beyond the epicardial coronary arteries - a case report

    Page :S138

    R. Bing, J. Lau, A. Yong, L. Kritharides

    
  • ·Cardiac troponin type II myocardial infarction and late mortality: a report from the 2012 SNAPSHOT OF ACS Care Across Australia and New Zealand

    Page :S139

    A. Etaher, D. Chew, T. Briffa, C. Ellis, C. Hammett, J. Redfern, J. Lefkovits, J. Elliott, L. Cullen, D. Brieger, J. French

    
  • ·Characterisation of coronary artery disease in a contemporary cohort of Australian patients with treated HIV, using invasive coronary angiography

    Page :S140

    E. O’Dwyer, P. Bhamra-Ariza, S. Rao, S. Emmanuel, C. Holloway

    
  • ·Characterisation of the glutathione peroxidase system in coronary artery disease

    Page :S140

    A. Holley, J. Miller, S. Harding, P. Larsen

    
  • ·Clinical appraisal of spontaneous coronary artery dissection (SCAD): A retrospective case series analysis

    Page :S140

    G. Gan, A. Bhat, A. Kanthan, A.R. Denniss

    
  • ·Clinical audit of antiplatelet therapy as part of Acute Coronary Syndrome management at Joondalup Health Campus

    Page :S141

    P. Naing, D. Thomson, J. Deague

    
  • ·Clinical outcomes for patients with stable coronary disease in Australia - findings from the CLARIFY registry

    Page :S141

    C. Reid, L. Shiel, M. Jelinek, B. Freedman, B. Hockings, P. Alwyard, I. Hamilton-Craig, P. Steg, I. Ford, K. Fox

    
  • ·Clinical outcomes of pharmaco-invasive ST-elevation myocardial infarction management in Bendigo, Victoria

    Page :S142

    B. Xu, V. Nadurata, K. Avery, C. Chilvers, S. Laiu

    
  • ·Clinical profile of acute myocardial infarction patients in the absence of significant coronary artery disease

    Page :S142

    S. Pasupathy, R. Tavella, M. Arstall, D. Chew, M. Worthley, C. Zeitz, J. Beltrame

    
  • ·Clinical risk stratification in non-ST elevation acute coronary syndromes (NSTEACS) – prevalence, accuracy and effect on treatment and outcomes

    Page :S143

    R. Bing, K. Hyun, M. D'Souza, R. Rajaratnam, D. Chew, D. Brieger

    
  • ·Comparing ambulance thrombolysis and in-hospital thrombolysis for patients diagnosed with ST elevation myocardial infarction

    Page :S143

    G. Femia, T. Fetahovik, T. Tiberio, W. Mckenzie, T. Nguyendang, D. Owensby, A. Yeung, P. Shetty, A. Lee

    
  • ·Consultation on scope determination in the development of the National Heart Foundation Of Australia (NHFA) / Cardiac Society of Australia and New Zealand (CSANZ) guidelines for the management of acute coronary syndromes 2015

    Page :S143

    M. Branagan, D. Chew, A. Wilson

    
  • ·Coronary vasospasm arising from neointima

    Page :S144

    E. Danson, R. Bhindi

    
  • ·Cultural factors, age and gender: Effects on attendance at chest pain clinic

    Page :S144

    A. Vlachadis Castles, I. Tsay, V. Liang, A. Gan, W. van Gaal

    
  • ·Determinants of death associated with out-of-hospital cardiac arrest presenting to a single tertiary referral hospital

    Page :S145

    J. Cole, N. Cox, N. Shah

    
  • ·Differences in cardiovascular risk factors and carotid IMT in Australian Indians and Caucasians with type-2 diabetes mellitus; an ethnic predisposition to atherosclerosis?

    Page :S145

    J. Harmer, C. Chow, B. McQuillan, D. Celermajer

    
  • ·Effect of tortuosity and wire stiffness on coronary measurement using optical coherence tomography

    Page :S145

    E. Danson, P. Hansen, R. Bhindi

    
  • ·Electrocardiographic measurement of infarct size correlates with cardiac magnetic resonance imaging in reperfused first-time STEMI patients

    Page :S146

    L. Holmes, T. Nguyen, D. Richards, L. Hee, J. Otton, D. Moses, L. Thomas, C. Juergens

    
  • ·Eosinophilic granulomatosis with polyangitis presenting as Acute Coronary Syndrome

    Page :S146

    A. Khan, A. Ashraf

    
  • ·Establishing a predictive model for aspirin resistance in elderly Chinese patients with chronic coronary heart disease

    Page :S147

    J. Cao, L. Gao, T. Chen, L. Fan

    
  • ·Establishment of a Rapid Access Chest Pain Clinic at the Royal Hobart Hospital

    Page :S147

    A. Elford, A. Black, J. Flood

    
  • ·Evaluation of cardiology rapid access clinics within a large NSW tertiary referral centre - pilot

    Page :S147

    H. Klimis, A. Thiagalingam, A. Bhaskaran, P. Kovoor, M. Vukasovic, R. Zecchin, R. Denniss, C. Chow

    
  • ·Evaluation of serial high sensitivity troponin T levels in individuals without overt coronary heart disease following exercise stress testing

    Page :S148

    Y. Saad, H. Idris, I. Shugman, J. Harris, K. Kadappu, R. Rajaratnam, C. Mussap, L. Thomas, C. Juergens, J. French

    
  • ·Evidence for early dynamic changes in apolipoproteins and lipids following minor coronary ischaemia

    Page :S148

    C. Judkins, S. Palmer, P. Williams, J. Garlick, I. Cook, R. Whitbourn, A. Wilson

    
  • ·False positive female stress ECG tests - fact or fiction?

    Page :S149

    G. Scalia, B. Fitzgerald

    
  • ·Four-dimensional coronary artery motion analysis predicts the location of culprit lesions causing myocardial infarctions

    Page :S149

    A. O’Loughlin, J. French, D. Richards, A. Denniss, J. Aben, A. Hennessy

    
  • ·Fractional flow reserve influences revascularisation decisions between interventional and non-interventional cardiologists

    Page :S150

    J. Shah, N. Nerlekar, D. Chee, B. Khialani, C. Hiew, L. Fredricks, M. Freilich, G. Toogood, P. Carillo, J. Layland

    
  • ·High-density lipoprotein infusion reduces inflammation and improves post-ischaemic heart function in healthy and insulin resistant mice

    Page :S150

    A. Richart, S. Heywood, H. Kiriazis, X. Du, A. Siebel, B. Kingwell

    
  • ·Impact of infarct size on left ventricular diastolic function following acute myocardial infarction

    Page :S151

    A. Lin, C. Kwan, K. Guppy-Coles, M. Dooris, L. Thomas, A. Dahiya, J. Atherton, S. Prasad

    
  • ·Implementation of “Non-physician led exercise stress testing” is effective to create access and optimise patient flow in tertiary, regional and rural hospitals

    Page :S151

    A. Scott, M. Whitman, A. McDonald, H. Cross, K. Pearson, C. Hughes

    
  • ·Incidence of myocardial infarction in young adults

    Page :S151

    N. Shah, V. Lee, K. Soon

    
  • ·Inhibition of the renin-angiotensin system (RAS) prevents inflammation associated cardiac rupture post myocardial infarction (MI)

    Page :S152

    X. Gao, A. Tsai, Y. Su, S. Moore, H. Kiriazis, X. Du

    
  • ·Index

    Page :S152

    
  • ·Is a single diagnostic catheter for radial approach coronary angiography cost effective?

    Page :S152

    P. Ganda

    
  • ·Is there a clinical difference in patients with acute coronary syndrome displaying Wellens type 1 versus type 2 patterns on ECG?

    Page :S153

    J. Kim, K. Haladyn, M. Zhang, S. Buchholz

    
  • ·Is there any gender difference in presentation, coronary intervention and outcomes of acute coronary syndrome patients in Victoria?

    Page :S153

    L. Worrall-Carter, S. McEvedy, A. Wilson, M. Rahman

    
  • ·Kawasaki disease: A review of 2 cases of sudden death

    Page :S154

    S. Parsons, M. Lynch

    
  • ·Less time since smoking cessation predicts acute coronary syndrome in high risk patients

    Page :S154

    A. Nguyen, H. Adams, J. Gin, N. Yap, A. Wilson

    
  • ·Management of ST elevation Myocardial Infarction (STEMI) in a rural New Zealand setting

    Page :S154

    T. Pegg, K. Gagliardi, M. Wilkinson, S. Wilson, N. Fisher

    
  • ·Massive right ventricular (RV) infarction masquerading as pulmonary embolism

    Page :S155

    M. Dooris

    
  • ·Mathematica: a flexible tool for data visualisation and analysis in cardiology

    Page :S155

    M. Dooris

    
  • ·Modelling- a future career option for the young research cardiologist

    Page :S155

    M. Mashicharan, D. McGill

    
  • ·Multiple bare metal stent thrombosis in the setting of metastatic lung cancer – despite triple therapy

    Page :S156

    H. Adams, A. Nguyen, S. Palmer, A. Burns, A. MacIsaac

    
  • ·Neutrophil-derived microparticles are acutely released into the coronary circulation following coronary angioplasty of unstable plaque

    Page :S156

    J. Barraclough, G. Martinez, S. Nakhla, D. Celermajer, S. Patel

    
  • ·Non-atherosclerotic acute myocardial infarction in young adults: a clinical challenge

    Page :S157

    F. Ilyas, P. Pati, M. Arstall

    
  • ·Obesity and age of presentation with symptomatic coronary artery disease

    Page :S157

    S. Atique, S. Moloi, A. Doost Hosseiny, P. Marley, A. Farshid

    
  • ·Out-of-hospital Cardiac Arrest (OOHCA) referred for Primary Percutaneous Coronary Intervention (PPCI): Results in a regional setting

    Page :S157

    S. Hayman, D. Colburn, K. Greaves, P. Larsen, R. Poulter, S. Butterly, Y. Chako, K. Lau, M. Nam, C. Thompson, A. Willson

    
  • ·Outcomes of drug eluting balloon in native coronaries & venous graft instent restenosis

    Page :S158

    A. Ghoshal, A. Mishra

    
  • ·Outcomes of drug eluting balloons in coronary revascularisation

    Page :S158

    L. Hee, A. Terluk, L. Thomas, A. Hopkins, C. Juergens, J. French, C. Mussap

    
  • ·Outcomes of the Queensland accelerated chest pain risk evaluation (ACRE) project

    Page :S159

    W. Skoien, L. Cullen, S. Ashover, J. Sippel, V. Bettens, W. Parsonage

    
  • ·Platelet activation by toll-like receptor (TLR)-9 agonism in acute coronary syndrome (ACS) patients on dual anti-platelet therapy

    Page :S159

    K. Hally, A. La Flamme, P. Larsen, S. Harding

    
  • ·Pre-hospital assessment for primary angioplasty (PAPA) versus traditional assessment in the emergency department

    Page :S160

    G. Femia, T. Fetahovik, T. Tiberio, W. Mckenzie, T. Nguyendang, D. Owensby, A. Yeung, P. Shetty, A. Lee

    
  • ·Predictors of delay to thrombolysis in STEMI patients in a peripheral centre

    Page :S160

    R. Gluer, I. Boteju, K. Haladyn, M. Zhang, S. Buchholz

    
  • ·Predictors of the uptake of invasive angiography in acute rapid atrial fibrillation/flutter with troponin rise

    Page :S160

    V. Cheng, C. Wang, C. Tan, N. Shah, S. Rametta, B. Zakhem

    
  • ·Pre-hospital thrombolysis for ST-segment elevation myocardial infarction (STEMI)

    Page :S161

    A. Khan, A. Boyle, P. Fletcher, L. Savage, P. Stewart, T. Williams

    
  • ·Pre-hospital thrombolysis in rural Victoria: successes and missed opportunities

    Page :S161

    E. Sinclair, K. Murdoch, P. Meddings

    
  • ·Presenting characteristics and management of chest pain among culturally and linguistically diverse populations: a comprehensive review

    Page :S162

    K. Wechkunanukul, H. Grantham, R. Clark

    
  • ·Prevalence of asymptomatic coronary heart disease in the siblings of young myocardial infarction patients

    Page :S162

    N. Shah, K. Soon, C. Wong, A. Kelly

    
  • ·Index

    Page :S162

    
  • ·Prevalence, clinical features and treatment of spontaneous coronary artery dissection: a single-centre experience

    Page :S162

    H. Rashid, A. Amiruddin, S. Gutman, H. Wijesekera, V. Shanmugam, D. Wong, Y. Malaiapan, I. Meredith, P. Psaltis

    
  • ·Randomised double blind placebo controlled study to determine the effects of vitamin D supplementation on platelet and vascular function in patients with vitamin D insufficiency and atherosclerotic disease

    Page :S163

    P. Ngu, H. Fernando, J. Liew, A. Dart, J. Wark, K. Peter, J. Shaw

    
  • ·Remote ischaemic preconditioning activates the JAK-STAT pathway resulting in the attenuation of Egr-1 expression following myocardial ischaemia reperfusion injury

    Page :S163

    H. Mudaliar, B. Rayner, M. Billah, W. Lay, R. Bhindi

    
  • ·Remote limb ischaemic preconditioning: contribution of vagal innervation to protection against myocardial ischaemia-reperfusion injury

    Page :S164

    C. Thomas, B. Feehan, C. May

    
  • ·Role of OCT in a case of VF arrest

    Page :S164

    M. Ramadan, N. Fisher, S. Wilson

    
  • ·Sex differences in the onset and experience of acute coronary syndrome

    Page :S164

    S. Cartledge, J. Bray, C. Arnold, D. Stub, P. Ngu, J. Shaw, J. Finn

    
  • ·Simultaneous thrombosis of two coronary arteries in STEMI: Successful treatment with thrombus aspiration and primary angioplasty

    Page :S165

    A. Davies, S. Thambar, A. Boyle

    
  • ·Smoking pack years increase risk of coronary artery disease in high risk patients

    Page :S165

    A. Nguyen, H. Adams, N. Yap, J. Gin, A. Wilson

    
  • ·Stent deformation and malapposition in saphenous vein grafts: optical coherence tomography guided confirmation and analysis

    Page :S165

    E. Danson, N. Mughal, R. Bhindi, P. Hansen

    
  • ·Suboptimal clinician adherence to evidence based use of anti-platelet therapy at the time of thrombolysis for ST-elevation myocardial infarction

    Page :S166

    B. Xu, V. Nadurata, K. Avery, C. Chilvers, S. Laiu

    
  • ·Supporting the provision of evidence-based care – developing a National ACS Capability Framework

    Page :S166

    B. Crosling, K. Page, D. Brieger

    
  • ·Temporal trends of coronary in-stent restenosis in an era of complex interventional cardiovascular therapy

    Page :S167

    V. Gupta, R. Parameswaran, S. Boo, S. Koneru, T. David, B. Herman

    
  • ·The association of delay in presentation and 12-month health outcomes in emergency patients with symptoms of possible acute coronary syndromes

    Page :S167

    L. Menzies, L. Cullen, J. Greenslade, A. Leong, M. Than, C. Pemberton, S. Aldous, J. Pickering, B. Crosling, R. Foreman, W. Parsonage

    
  • ·The fat scan study: correlation of visceral adipose tissue to coronary atherosclerosis in a multi-ethnicity Australian population

    Page :S168

    S. Binny, A. Dahiya, P. Challa, D. Hardman, C. Jeffries

    
  • ·The impact of three different glycoprotein platelet receptor IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes

    Page :S168

    L. Holmes, R. Gupta, S. Rajendran, J. Luu, J. French, C. Juergens

    
  • ·The importance of evaluating patients with MINOCA (Myocardial infarction with non-obstructive coronary arteries)

    Page :S169

    A. Sheikh, S. Sidharta, S. Pasupathy, M. Worthley, J. Beltrame

    
  • ·The role of CT Coronary Angiogram in a Regional setting to improve access to care for Indigenous and non-Indigenous Australians

    Page :S169

    A. Antoo, N. Kangaharan, B. Ko, W. Corkill, I. Agahari, S. Brady

    
  • ·Therapeutic role of TLR9 agonist in the atherosclerosis

    Page :S170

    Y. Chen, C. Koulis, A. Bobik, A. Agrotis, K. Peter

    
  • ·TMEM198 is a potential marker of ruptured plaque but not coronary ischaemia

    Page :S170

    C. Judkins, S. Palmer, P. Williams, J. Garlick, I. Cooke, R. Whitbourn, A. Wilson

    
  • ·Trends in incidence and prevalence of hospitalisation for atrial fibrillation and associated mortality in Western Australia, 1995–2010

    Page :S171

    T. Briffa, J. Hung, M. Knuiman, B. McQuillan, D. Chew, J. Eikelboom, G. Hankey, L. Nedkoff, R. Weerasooriya, A. Liu, P. Stobie

    
  • ·Troponin positive patients with unobstructed coronaries: Incremental value of Cardiovascular Magnetic Resonance over expert clinical judgment

    Page :S171

    B. Raman, B. Pathik, N. Amin, G. Mahadavan, S. Rajendran, S. Grover, E. Smith, J. Mazhar, C. Bridgman, A. Ganesan, J. Selvanayagam

    
  • ·Use of oral anticoagulation combined with single versus dual antiplatelet therapy in those undergoing percutaneous coronary intervention: A meta-analysis

    Page :S172

    S. Gnanenthiran, D. Brieger

    
  • ·Validation of the prognostic value of percentage total plaque score normalised to age on coronary computed tomography

    Page :S172

    C. Ayoub, S. Achenbach, M. Al-Mallah, D. Andreini, D.S. Berman, M.J. Budoff, F. Cademartiri, T.Q. Callister, H. Chang, K.M. Chinnaiyan, R.C. Cury, A. Delago, A.M. Dunning, G. Feuchtner, M. Gomez, H. Gransar, M. Hadamitzky, J. Hausleiter, N. Hindoyan, E. Jones, P.A. Kaufmann, Y. Kim, J. Leipsic, F.Y. Lin, E. Maffei, H. Marques, G. Pontone, G. Raff, R. Rubinshtein, L.J. Shaw, T.C. Villines, J. Min, B. Chow

    
  • ·Variability of delay time in seeking medical care for chest pain: a global review

    Page :S173

    K. Wechkunanukul, H. Grantham, R. Clark

    
  • ·Vascular access in cath lab, costs and complications

    Page :S173

    M. Ramadan, T. Pegg, N. Fisher

    
  • ·Vulnerable plaque features on computed tomography coronary angiography are associated with long-term acute coronary syndrome events

    Page :S173

    R. Munnur, R. Muthalaly, B. Ko, L. Potter, A. Talman, Y. Bae, S. Qian, H. Au-Yeung, D. Tharmaratnam, J. Nogic, J. Moghadas, J. Cameron, I. Meredith, S. Seneviratne, D. Wong

    
  • ·Women admitted to hospital after out-of-hospital cardiac arrest have fewer culprit ‘ACS’ lesions on the coronary angiogram

    Page :S174

    M. Wittwer, Y. Chow, M. Arstall

    
  • ·Yield of routine provocative testing among patients assessed in a large tertiary centre chest pain assessment service

    Page :S174

    J. Antony, B. Jahangiri, M. Paymard, M. Carroll, B. Bell

    
  • ·A surgical myectomy program to manage complex obstructive hypertrophic cardiomyopathy

    Page :S175

    B. Gray, P. Bannon, B. Bailey, S. Lal, L. Yeates, D. Richmond, M. Byrom, C. Semsarian, C. Medi

    
  • ·Aging is protective against pressure overload cardiomyopathy - focus on extracellular matrix changes

    Page :S175

    B. Coulter, X. Geng, C. Naudin, J. Hwang, J. Ye, R. Sievers, Y. Yeghiazarians, R. Lee, A. Boyle

    
  • ·Annexin-a1 deficiency exaggerates cardiac injury following myocardial infarction (MI) in vivo

    Page :S176

    C. Qin, S. Finlayson, S. Rosli, M. De Blasio, C. Thomas, A. AI-Sharea, A. Murphy, H. Kiriazis, Y. Yang, E. Morand, X. Du, X. Gao, R. Ritchie

    
  • ·Characterising effects of a peptide directed against the L-type Ca2+ channel on mitochondrial function in hypertrophic cardiomyopathy

    Page :S176

    H. Viola, V. Johnstone, H. Cserne Szappanos, T. Tsoutsman, C. Semsarian, C. Seidman, L. Hool

    
  • ·CRISPR-like genome editing tool-mediated down regulation of CAMK2D: A potential role for epigenetics intervention in the treatment of cardiac hypertrophy

    Page :S177

    J. Constantine, A. Sgro, C. Moses, P. Blancafort, L. Hool

    
  • ·Early relief of aortic coarctation results in complete regression of cardiac hypertrophy and associated changes in the transcriptome; an animal model

    Page :S177

    S. Chen, D. Drak, A. Krishnan, W. Li, G. Denyer, D. Celermajer, J. Liu

    
  • ·Epicatechin improves diastolic stiffness and preserves left ventricular function within the hypertrophied DOCA-salt rat heart

    Page :S178

    D. Jackson, K. Connolly, G. Buitrago, F. Coulson, A. Fenning

    
  • ·Evaluating off-label use of tilorone as a novel therapeutic for hypertrophic cardiomyopathy

    Page :S178

    B. Bernardo, C. Winbanks, X. Gao, Y. Tham, T. Pongsukwechkul, H. Kiriazis, X. Du, P. Gregorevic, J. McMullen

    
  • ·Identification of novel cardioprotective miRNAs and mRNAs regulated by miR-34

    Page :S179

    J. Ooi, B. Bernardo, R. Lin, J. McMullen

    
  • ·Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways

    Page :S179

    I. Wang, L. Huang, P. Fu, B. Wang, L. Bach, H. Krum

    
  • ·Key functional domains of human cardiac troponin-C are susceptible to advanced glycation end-product formation in vitro

    Page :S180

    B. Ma, K. Mellor, L. Delbridge

    
  • ·Lucky escape: aborted sudden cardiac death in cardiac sarcoidosis

    Page :S180

    T. Ford, J. Matthews

    
  • ·MicroRNA-34a and tert act as epi-drivers of cardiac telomere length and polygenic cardiac hypertrophy

    Page :S180

    S. Booth, F. Marques, P. Prestes, C. Curl, L. Delbridge, P. Lewandowski, S. Harrap, F. Charchar

    
  • ·Mitral valve prolapse and sudden death: a systematic review

    Page :S181

    C. Nalliah, R. Mahajan, H. Haqqani, D. Lau, J. Vohra, J. Morton, J. Kalman, P. Sanders

    
  • ·Optimising morpholino oligomer therapy in the treatment of mdx cardiomyopathy

    Page :S181

    V. Johnstone, H. Viola, A. Adams, S. Wilton, S. Fletcher, L. Hool

    
  • ·Reduced selenium levels in ? thalassaemia major are associated with impairment of left ventricular systolic function

    Page :S182

    R. Peverill, D. Bowden, M. Chen, M. Chia, F. Rosenfeldt

    
  • ·Reversal of pathological responses to pressure overload by inhibition of phospholipase C beta1b

    Page :S182

    D. Grubb, X. Du, J. McMullen, E. Woodcock

    
  • ·Index

    Page :S183

    
  • ·The distinctive micro-RNA expression signature of human embryonic stem cell-derived cardiomyocytes

    Page :S183

    D. Arasaratnam, D. Elliott, T. White

    
  • ·TRPC6 (transient receptor potential Ca2+ channel 6) activity in the atrial endocardium exposed to increased mechanical stress is determined by the duration of the mechanical stretch stimuli

    Page :S183

    V. Nikolova-Krstevski, S. Wagner, J. Cvetkovska, B. Martinac, O. Friedrich, D. Fatkin

    
  • ·A robust rodent model of the metabolic syndrome and hypogonadism representative of aged males for applications in cardiometabolic research

    Page :S184

    D. Donner, G. Elliott, B. Beck, A. Bulmer, E. Du Toit

    
  • ·AMPK regulation of cardiomyocyte glycogen handling and autophagic signalling is dependent on extracellular glucose status

    Page :S184

    U. Varma, K. Mellor, L. Delbridge

    
  • ·Biomarkers and risk of atrial fibrillation: a systematic review and meta-analysis

    Page :S185

    R. Pathak, J. Sen, A. Mehta, C. Wong, M. Alasady, D. Lau, W. Abhayaratna, P. Sanders

    
  • ·Candidates for novel lipid-lowering therapies: persistently high on-treatment LDL-C in STEMI and NSTEMI patients

    Page :S185

    N. Hann, N. Yap, J. Gin, A. Nguyen, H. Adams, A. Wilson

    
  • ·Cardiomyopathy, hypercoagulability and inflammation in patients with schizophrenia

    Page :S186

    V. Chow, T. Yeoh, C. Reddel, G. Pennings, E. Scott, J. Curnow, A. Ng, L. Kritharides

    
  • ·Diabetic patients undergoing coronary artery bypass grafting: effects of haemoglobin A1c and peri-operative glucose levels

    Page :S186

    T. Wang, A. Woodhead, J. Pemberton, T. Ramanathan

    
  • ·Effects of high intensity interval training on health: a systematic review of intervention studies

    Page :S187

    R. Batacan, A. Fenning, M. Duncan, V. Dalbo

    
  • ·Epicatechin improves lipid profile and oxidative stress status, but does not reduce abdominal fat or blood pressure in an obese SHR model of metabolic syndrome

    Page :S187

    K. Connolly, D. Jackson, R. Batacan, A. Fenning

    
  • ·High prevalence of suboptimal lipid management in the elderly: A call for new treatment guidelines

    Page :S188

    D. Colquhoun, I. Hamilton-Craig, K. Kostner, S. Woodhouse, M. d’Emden

    
  • ·High-density lipoprotein (HDL) is a novel activator of cardiac glucose metabolism in both healthy and insulin resistant mice

    Page :S188

    S. Heywood, D. Henstridge, A. Richart, K. Alt, A. Carey, H. Kammoun, L. Delbridge, C. Hagemeyer, M. Febbraio, B. Kingwell, A. Siebel

    
  • ·Increasing renal impairment predicts lower low-density lipoprotein levels independent of statin use in high cardiovascular risk patients

    Page :S188

    N. Yap, J. Gin, A. Nguyen, H. Adams, A. Wilson

    
  • ·Iatrogenic anterior myocardial infarction secondary to ergometrine-induced coronary artery spasm during dilation and curettage for an incomplete miscarriage

    Page :S189

    J. Ramzy, G. New, A. Cheong, L. Roberts, A. Teh

    
  • ·Late gestation over nutrition alters the cardiac metabolic profile

    Page :S189

    J. Darby, S. Zhang, I. McMillen, B. Mühlhausler, J. Morrison

    
  • ·Left ventricular global longitudinal strain is associated with novel uraemic toxins, obesity and arterial stiffness in chronic kidney disease

    Page :S190

    T. Stanton, R. Krishnasamy, C. Hawley, E. Pascoe, K. Campbell, M. Rossi, K. Beetham, W. Patchey, J. Coombes, R. Leano, B. Haluska, N. Isbel

    
  • ·Statins: Review of safety and potential side effects

    Page :S190

    S. Ramkumar, A. Wilson

    
  • ·The effect of chronic pravastatin therapy on ischaemic tolerance and oxidative stress defense mechanisms in obese rats

    Page :S190

    E. Du Toit, O. Evans, M. Oi, D. Donner, J. Vanderlelie, J. Peart

    
  • ·The PKD inhibitor CID755673 enhances heart function in diabetic db/db mice

    Page :S191

    K. De Jong, S. McGee, K. Venardos, T. Connor, M. Elkamie

    
  • ·The role of fenofibrate in metabolic reprogramming in hyperglycaemia and hypoxia

    Page :S191

    E. King, S. Chen, J. Yuan, A. Jenkins, A. Keech, M. Ng

    
  • ·TNF-?, foam cells and abdominal aortic wall thickness in rats with subchronical inhalation exposure of transfluthrin

    Page :S192

    A. Prameswari, D. Soeatmadji

    
  • ·Visible age-related signs in a patient presenting with a myocardial infarction

    Page :S192

    D. Chee, S. Narayanasamy, D. Clinton, N. Nerlekar

    
  • ·A case report on Double Valve Repair for Hypereosinophilic Syndrome

    Page :S192

    A. Al-Kaisey, J. Ramchand, P. Hayward, E. Jones

    
  • ·A snapshot of acute decompensated heart failure across New South Wales. Baseline results from the NSW HF Snapshot

    Page :S193

    P. Newton, P. Davidson, C. Reid, P. Macdonald

    
  • ·Index

    Page :S193

    
  • ·Achieving medication titration for patients with heart failure in the real world

    Page :S193

    A. Hickey, J. Suna, L. Marquart, G. Javorsky, A. Munns, C. Denaro, A. Mudge, J. Atherton

    
  • ·Adherence Rate to Guideline Directed Therapy in Patients with Systolic Heart Failure

    Page :S194

    S. Reny, A. Rischin, P. Carillo, J. Layland

    
  • ·Adopting a Mediterranean diet slows the progression of established heart failure arising from myocardial infarction

    Page :S194

    D. Drak, A. Krishnan, W. Stanley, D. Celermajer, J. Liu

    
  • ·Altered myogenic transcription factors and clinical markers in early stage cardiac hypertrophy due to cancer cachexia

    Page :S194

    T. Tan, M. McGill, R. Falconer, A. Bradd, N. Bentley, P. Polly

    
  • ·Amphetamine-induced cardiomyopathy: Patterns and predictors of recovery

    Page :S195

    A. Voskoboinik, J. Ihle, D. Kaye

    
  • ·An article examining the changes in age, health complexity and disease type in people seen by a heart failure outreach service in Sydney from 2002-2014

    Page :S195

    R. Wickham, M. King, J. McVeigh

    
  • ·An in vitro cardiomyocyte model for assessing altered autophagic marker expression due to elevated cytokines

    Page :S196

    T. Tan, R. Falconer, P. Polly

    
  • ·An in vitro model of acute myocardial damage in human bioengineered heart muscle

    Page :S196

    H. Voges, R. Mills, E. Porrello, J. Hudson

    
  • ·Aromatase expression in myocardium and pericardial adipose – influence of sex and hypertrophy

    Page :S196

    G. Bernasochi, A. Raaijmakers, C. Curl, W. Boon, W. Ip, S. Pepe, S. Harrap, L. Delbridge, J. Bell

    
  • ·Aspirin withdrawal in stable heart failure patients results in no change in clinical status or quality of life

    Page :S197

    I. Hopper, M. Skiba, A. Tonkin, H. Krum

    
  • ·Assessment of management for heart failure with preserved ejection fraction

    Page :S197

    F. Lee, D. Bachmann, B. McQuillan

    
  • ·Audit of adherence to guidelines for heart failure in a private cardiology clinic in Greater Newcastle Region, Australia

    Page :S198

    A. Worthington, T. McCallum Pardy

    
  • ·Baseline functional capacity in patients with heart failure risk factors: association with heart failure symptoms and events at 1 year follow-up

    Page :S198

    H. Yang, K. Negishi, M. Nolan, Y. Wang, M. Saito, T. Marwick

    
  • ·Calcium dysregulation and arrhythmia underlie hypertrophic heart failure with preserved ejection fraction

    Page :S199

    C. Curl, A. Raaijmakers, C. Chandramouli, T. Harding, J. Bell, S. Harrap, L. Delbridge

    
  • ·Cardiomyocyte mineralocorticoid receptor regulates cardiac functional responses to ischaemia; the role of sex and NOS inhibition

    Page :S199

    L. Bienvenu, J. Morgan, L. Delbridge, M. Young

    
  • ·Circadian variation of haemodynamic parameters during continuous-flow ventricular assist device support

    Page :S200

    N. Jain, D. Vickers, M. Granegger, H. Schima, F. Moscato, P. Macdonald, P. Jansz, C. Hayward

    
  • ·Circulating receptor for advanced glycation end products (RAGE) is a risk factor for developing heart failure

    Page :S200

    T. Lancefield, M. Freeman, S. Patel, E. Velkoska, M. Horrigan, O. Farouque, L. Burrell

    
  • ·Clinical characteristics and long-term outcomes in patients with acute ST-segment elevation myocardial infarction involving the right coronary artery or dominant left circumflex artery treated with primary percutaneous coronary intervention

    Page :S201

    R. Markham, Y. Wong, D. Walters, D. Wright, S. McKenzie

    
  • ·Clinical outcome of patients hospitalised for heart failure treated by cardiology versus general medicine

    Page :S201

    R. Suryani, E. Johnsamuel Ponnusamy, J. Chu, H. Yuvaraj, A. Yeap, B. Khialani, J. Layland

    
  • ·Current strategies employed by nurses used to manage the symptom of thirst in chronic heart failure

    Page :S202

    S. Allida, S. Inglis, P. Davidson, P. Newton, C. Hayward

    
  • ·Dental-associated viridans streptococci bloodstream infection in patients with continuous-flow ventricular assist devices

    Page :S202

    C. Dowling, C. Lim, N. Kerr, S. Rao, D. Robson, P. Macdonald, E. Kotlyar, A. Jabbour, C. Hayward, A. Keogh

    
  • ·Derivation of left atrial pressure from flow analysis in continuous-flow left ventricular assist devices

    Page :S202

    D. Vickers, S. Shehab, N. Jain, S. Rao, A. Jabbour, P. Jansz, C. Hayward

    
  • ·Digoxin withdrawal in patients with stable heart failure receiving optimal contemporaneous therapy worsens heart failure status but better preserves quality of life

    Page :S203

    I. Hopper, M. Skiba, T. Von Lueder, M. Watanabe, A. Tonkin, H. Krum

    
  • ·Disagreement between thermodilution and indirect Fick cardiac outputs in a mixed pulmonary hypertension and heart failure population

    Page :S203

    N. Kerr, R. Prichard, C. Dowling, S. Rao, C. Lim, F. Koppe, A. Jabbour, E. Kotlyar, P. Macdonald, C. Hayward, A. Keogh

    
  • ·Dynamics of structured telephone support in a trial of hybrid face-to-face and remote follow-up of typically old and high risk individuals recently discharged from hospital with heart failure

    Page :S204

    N. Emanuele, S. Stewart

    
  • ·Early intervention in systolic heart failure = early recovery in LV ejection fraction

    Page :S204

    S. Lockwood, C. Bowman, J. Cameron

    
  • ·Early mobilisation of a continuous flow ventricular assist device patient cohort: a tertiary centre experience

    Page :S204

    H. Seale, J. Bancroft, J. King, A. Dunning, S. Tang, S. McKenzie, G. Javorsky

    
  • ·Effect of tolvaptan on congestive heart failure patients with reduced stroke volume

    Page :S205

    H. Nakano, M. Watanabe, M. Kobayashi, A. Yamashina

    
  • ·Estimating the current and future incidence and prevalence of heart failure in the Australian adult population

    Page :S205

    Y. Chan, J. Ball, T. Teng, C. Tuttle, Y. Ahamed, M. Carrington, S. Stewart

    
  • ·Estimation of systemic blood pressure from pump parameters in continuous-flow left ventricular assist devices

    Page :S205

    D. Vickers, S. Shehab, N. Jain, D. Robson, S. Rao, A. Jabbour, P. Jansz, C. Hayward

    
  • ·Index

    Page :S206

    
  • ·Fibrosis of the Transverse Tubules in human heart failure

    Page :S206

    D. Crossman, X. Shen, M. Jüllig, D. Baddeley, P. Ruygrok, C. Soeller

    
  • ·Heart failure in an Indigenous Australian population

    Page :S206

    C. Tuttle, G. Maguire, S. Stewart

    
  • ·Heart failure mortality following treatment for blood and breast cancer

    Page :S207

    M. Chowdhury, R. Clark

    
  • ·Heart rate target treatment shortfall in contemporary beta-blocker therapy of heart failure in 446 patients in sinus rhythm

    Page :S207

    G. Scalia, I. Scalia, W. Scalia, L. Rafter, T. Rafter, D. Cross

    
  • ·Impact of either short- or long-term right heart support on continuous flow LVAD outcomes

    Page :S208

    S. Rao, S. Shehab, J. Lewis, K. De Silva, R. Desiree, M. Connellan, P. Macdonald, A. Keogh, A. Jabbour, E. Kotlyar, E. Granger, P. Spratt, K. Dhital, P. Jansz, C. Hayward

    
  • ·Impact of left ventricular function on outcomes following percutaneous coronary intervention

    Page :S208

    L. Selkrig, N. Andrianopoulos, S. Nanayakkara, H. Krum, A. Dart, D. Clark, A. Brennan, J. Shaw, A. Ajani, G. New, C. Hiew, S. Duffy

    
  • ·Incidence of heart failure in elderly hypertensive patients

    Page :S209

    B. Sahle, A. Owen, H. Krum, C. Reid

    
  • ·In-vitro assessment of the HeartWare HVAD in a biventricular configuration

    Page :S209

    S. Shehab, D. Vickers, N. Jain, P. Newton, P. Davidson, P. Jansz, P. Macdonald, C. Hayward

    
  • ·Iron Deficiency (ID) in patients with Ventricular Assist Devices (VADs) and improvement in functional exercise capacity with intravenous iron supplementation

    Page :S209

    M. Stokes, M. Watts, D. Kaye, L. Fuller, R. Stornebrink

    
  • ·Is the sum greater than the whole? Association of heart risk factors and echocardiographic parameters with reduction in 6-minute walk test in stage A heart failure

    Page :S210

    M. Nolan, Y. Wang, H. Yang, T. Marwick

    
  • ·LCZ696, an angiotensin receptor neprilysin inhibitor, attenuates renal fibrosis after myocardial infarction and reduces angiotensin-II-mediated renal cellular collagen synthesis

    Page :S210

    B. Wang, T. von Lueder, A. Kompa, L. Huang, R. Webb, P. Jordaan, D. Atar, H. Krum

    
  • ·Lipophilic statin versus hydrophilic statin treatment on cardiac function and inflammation in heart failure: A systematic review and an adjusted indirect comparison meta-analysis

    Page :S211

    K. Osei Bonsu, A. Kadirvelu, D. Reidpath

    
  • ·Loss of the peripheral molecular clock blunts the cardiac response to mineralocorticoid induced cardiovascular disease

    Page :S211

    E. Fletcher, J. Morgan, L. Delbridge, M. Young

    
  • ·Lung surfactant in chronic heart failure patients

    Page :S212

    C. De Pasquale, D. Dixon, G. Crouch, M. Lawrence, S. Bihari, A. Bersten

    
  • ·Management of patients admitted with acute decompensated heart failure in a tertiary metropolitan hospital

    Page :S212

    C. Bird, R. Sanders, B. Smith, H. Gock, W. Beswick, S. Bateman, D. Prior

    
  • ·Measuring mitochondrial function in multicellular cardiac trabeculae

    Page :S212

    A. Power, M. Ward, D. Crossman, A. Hickey

    
  • ·Microangiopathy masquerading as peripartum cardiomyopathy

    Page :S213

    J. Fanning, D. Platts, K. Shekar, N. Raju, J. Fraser

    
  • ·Not all cardiac glycosides are equal: Could ouabain prove to be better than digoxin for heart failure?

    Page :S213

    A. Garcia, C. Liu, W. Hannam, N. Fry, H. Rasmussen

    
  • ·Obesity and activity in heart transplant: Is obesity post heart transplant related to patient activity levels?

    Page :S213

    S. McKenzie, R. Francis, W. Chan, G. Javorsky, N. Morris, J. Walsh

    
  • ·Optimisation serum sodium concentrations in heart failure patients: The potential role of tolvaptan

    Page :S214

    M. Kobayashi, K. Teraoka, Y. Iwasaki, M. Watanabe, K. Takazawa, A. Yamashina

    
  • ·Orchestrated role of cardiovascular microRNAs in diabetic cardiomyopathy

    Page :S214

    S. Rawal, E. Munasinghe, A. Shindikar, P. Manning, R. Katare

    
  • ·Phosphoinositide 3 kinase p110a (rAAV6-caPI3K) gene therapy attenuates diabetic cardiomyopathy in mice

    Page :S214

    D. Prakoso, M. DeBlasio, H. Kiriazis, S. Rosli, C. Qin, X. Jun Du, J. McMullen, R. Richie

    
  • ·Primary adrenal insufficiency in a 19-year-old male presenting with cardiomyopathy

    Page :S215

    T. Pasley, M. Farrant, N. Amir, S. Young

    
  • ·Progression of low grade aortic regurgitation

    Page :S215

    J. Ramzy, R. Prawer, A. Gorelik, L. Roberts, J. Cooke, G. New, T. Barton

    
  • ·Retained cardiac implantable electronic devices post orthotopic heart transplantation: prevalence and complications

    Page :S216

    A. Koshy, S. Nanayakkara, J. Martin, P. Bergin, J. Mariani

    
  • ·Role of N-Acetyl Cysteine in reducing heart damage in a mouse model of heart failure

    Page :S216

    B. Giam, N. Rajapakse, P. Chu, D. Kaye

    
  • ·SAPHIRE: stress and pulmonary hypertension in rheumatoid evaluation - a prevalence study

    Page :S217

    N. Collins, G. Reeves, P. Hayes, J. Knapp, M. Squance, S. Oakley, H. Tran, G. Major

    
  • ·Serum amino-terminal-pro-B-type natriuretic peptide (NT-proBNP) level is superior to Framingham risk score for the prediction of heart failure (HF) and other cardiovascular (CV) events in individuals aged ?60 years with ?1 CV risk factor: interim analysis of the Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF) study

    Page :S217

    D. Campbell, M. McGrady, D. Prior, J. Coller, U. Boffa, L. Shiel, D. Liew, R. Wolfe, S. Stewart, C. Reid, H. Krum

    
  • ·Sex-differences in AngII-mediated exacerbation of diabetic myocardial function

    Page :S218

    C. Chandramouli, M. Reichelt, R. Ritchie, C. Curl, K. Mellor, L. Delbridge

    
  • ·Statin withdrawal in stable heart failure patients results in no change in clinical status or quality of life

    Page :S218

    I. Hopper, M. Skiba, A. Tonkin, H. Krum

    
  • ·Tako-tsubo cardiomyopathy is associated with loss of anti-inflammatory effect of released B-type natriuretic peptide

    Page :S218

    S. Liu, D. Ngo, B. Raman, C. Chong, J. Stansborough, Y. Chirkov, F. Ilyas, J. Horowitz

    
  • ·The angiotensin receptor neprilysin inhibitor LCZ696 improves systolic cardiac function compared to angiotensin converting enzyme inhibition (ACEi) in a rat model of myocardial infarction

    Page :S219

    A. Kompa, T. Weller, T. von Lueder, B. Wang, H. Krum

    
  • ·The conundrum of multimorbidity in heart failure: Increased risk of 30-day readmission despite disease management

    Page :S220

    L. Bonney, D. Thompson, Y. Ahamed, Y. Chan, S. Stewart

    
  • ·The efficacy of the heart failure follow-up clinic (HFFC) in the management of chronic heart failure: An Australian centre experience

    Page :S220

    A. Bhat, G. Gan, T. Suo, C. Tyers, B. Jenkins, D. Changsiri, S. Eshoo, R. Turner, A. Denniss

    
  • ·The relationship of temperature and air pollution with heart failure and possible protective effects of beta-blockers

    Page :S221

    Q. Huynh, F. Johnston, T. Marwick, K. Negishi

    
  • ·The Self-Care Educational Intervention study: study protocol of a randomised controlled trial

    Page :S221

    M. Boyde, R. Peters, R. Hwang, D. Korczyk, T. Ha, N. New

    
  • ·Trans-pulmonary physiology in patients with severe left ventricular dysfunction using ePLAR (echocardiographic Pulmonary to Left Atrial Ratio) – relationship with heart rate response to beta-blocker therapy

    Page :S221

    I. Scalia, W. Scalia, D. Cross, L. Rafter, T. Rafter, G. Scalia

    
  • ·Unilateral cardiogenic pulmonary oedema secondary to severe mitral regurgitation

    Page :S222

    C. Cheshire, J. Martin, S. Lovibond, C. Hengel

    
  • ·Use of extracorporeal membrane oxygenation for mechanical circulatory support in a patient with 5-fluorouracil -induced acute heart failure

    Page :S222

    S. Rateesh, B. Bhaskar, R. Naidoo, K. Shekar, D. Mittal

    
  • ·Using patient journey data to improve heart failure service design and practice

    Page :S223

    D. Gascard, J. White, W. Rourke

    
  • ·Ventricular impairment after pericardiocentesis: Stress Cardiomyopathy (SCM) or Pericardial Decompression Syndrome (PDS)?

    Page :S223

    C. Ayoub, M. Chang, L. Kritharides

    
  • ·A novel kinetic model based on the Albers-Post scheme that mimics the behaviour of the Na+, K+-ATPase in situ

    Page :S224

    A. Garcia, H. Rasmussen, R. Clarke

    
  • ·A retrospective analysis of ECG event loop recorders, diagnostic yield versus duration

    Page :S224

    L. Cleave, J. Hill, W. Vollbon

    
  • ·An unusual case of transient conduction disturbance

    Page :S224

    N. Whitehead, M. Barlow

    
  • ·Cardiac asystole and insular epilepsy. The chicken or the egg?

    Page :S225

    C. Booth, G. Kaye, H. Brown

    
  • ·Circuit impedance could be a crucial factor influencing radiofrequency efficacy and safety. A myocardial phantom study

    Page :S225

    A. Bhaskaran, T. Barry, J. Pouliopoulos, W. Chik, J. Dandach, A. Mc Ewan, R. Samanta, M. Farraha, J. Ng, S. Thomas, P. Kovoor, A. Thiagalingam

    
  • ·Conscious sedation for electrophysiological procedures: a prospective multi centre experience

    Page :S226

    R. Markham, P. Martin, K. Chia, A. Westerink, R. Denman

    
  • ·Electrophysiological remodelling in a rodent model of early onset type II diabetes mellitus

    Page :S226

    M. Neo, W. Lim, D. Lau, P. Sanders, D. Saint

    
  • ·Epidemiology of cardiac electrophysiology in Australia (1994–2013)

    Page :S226

    W. Ahmad, B. Wilsmore

    
  • ·Fluid column pacing vs conventional temporary pacing: A comparative study in the animal model

    Page :S227

    R. Samanta, A. Bhaskaran, M. Farraha, M. Barry, K. Byth, J. Pouliopoulos, S. Thomas, A. Thiagalingam

    
  • ·Heart rate variability and ECG alterations in a murine model of hypertrophic cardiomyopathy

    Page :S227

    W. Lim, M. Baumert, M. Neo, P. Kuklik, A. Ganesan, D. Lau, T. Tsoutsman, C. Semsarian, P. Sanders, D. Saint

    
  • ·High grade second degree atrioventricular block in 23-year-old female with subclinical hypothyroidism

    Page :S228

    K. Lau, N. Dayanada

    
  • ·In search of the protein kinase A phosphorylation sites on the human cardiac L-type calcium channel alpha subunit

    Page :S228

    H. Cserne Szappanos, P. Muralidharan, E. Ingley, L. Hool

    
  • ·Left atrial appendage thrombus during anticoagulation with rivaroxaban

    Page :S229

    B. Jahangiri, M. Habibian, R. Denman

    
  • ·Prospective assessment of initial electrical ring gaps during isolation of pulmonary veins with a single continuous circular ring (Box lesion)

    Page :S229

    F. Nadri, S. Thomas, A. Thiagalingam, P. Qian

    
  • ·Substrate for Atrial Fibrillation: A Rodent Model of Streptozotocin-Induced Type I Diabetes

    Page :S229

    M. Neo, W. Lim, D. Lau, P. Sanders, D. Saint

    
  • ·Sudden cardiac arrest associated with application of shocks from a TASER Electronic Control Device

    Page :S230

    J. England, W. Brown, J. Dearin

    
  • ·The effect of different rates of weight gain on atrial electrophysiology

    Page :S230

    D. Twomey, R. Mahajan, S. Thanigaimani, S. Willoughby, A. Rajwani, D. Lau, P. Sanders

    
  • ·The effect of endothelin-receptor blockade on atrial electrophysiology in obesity

    Page :S231

    D. Twomey, R. Mahajan, S. Thanigaimani, A. Rajwani, D. Lau, P. Sanders

    
  • ·The Influence of Vein Size, Cryoballoon Diameter and Balloon-Vein Angulation on Tissue Temperature: An In-Vitro Study

    Page :S231

    P. Kabunga, E. Hodkinson, H. Abed, M. McGuire

    
  • ·The reflex response to Lower Body Negative Pressure (LBNP) is altered in Paroxysmal Atrial Fibrillation (PAF) Patients: Pulmonary Vein Isolation (PVI) has no effect on LBNP response

    Page :S232

    V. Malik, D. Mckitrick, V. Paul, L. Arnolda

    
  • ·The role of in vitro phenotypes for clinical risk stratification of sudden death in Long QT Syndrome Type 2

    Page :S232

    K. Phan, C. Ng, S. McNitt, A. Moss, W. Zareba, M. Perry, J. Vandenberg

    
  • ·The safety of a nurse-led day case cardioversion service in the novel oral anticoagulant era: a single centre experience

    Page :S233

    P. Moore, N. Lollback, L. Slater, P. Gould, J. Hill, G. Kaye

    
  • ·Weight confirmed as a risk factor for atrial fibrillation in 39,023 subjects

    Page :S233

    T. White, J. Cameron, P. Mottram

    
  • ·What are the odds? A rare complication of a rare cardiac syndrome occurring in the rarest of circumstances

    Page :S233

    S. Gutman, S. Moir

    
  • ·A meta-analysis of randomised controlled trials on the effect of right ventricular apical and non-apical pacing on left ventricular ejection fraction

    Page :S234

    G. Kaye, M. Hussain, L. Furuya-Kanamori, J. Clark, S. Doi

    
  • ·A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomised controlled trial (the Minimax Study)

    Page :S235

    A. McLellan, L. Ling, S. Azzopardi, G. Lee, G. Lee, S. Kumar, M. Wong, T. Walters, J. Lee, K. Halloran, M. Stiles, N. Lever, S. Fynn, P. Heck, P. Sanders, J. Morton, J. Kalman, P. Kistler

    
  • ·A multicentre study of AF ablation outcomes in patients with concurrent left ventricular dysfunction - aetiology of cardiomyopathy determines outcome

    Page :S235

    S. Prabhu, L. Ling, R. Hunter, R. Schilling, A. McLellan, M. Earley, S. Sporton, A. Voskoboinik, S. Nanayakkara, J. Mariani, G. Lee, P. Kistler

    
  • ·Another mechanism of Riata lead failure - out of mind, out of sight?

    Page :S236

    A. Lee, B. Jahangiri, H. Haqqani, R. Denman

    
  • ·Arrhythmia detection via remote monitoring of cardiac devices: the MonashHeart experience

    Page :S236

    V. Mutha, A. Robertson, N. Youngs, D. Adam, J. Krafchek, L. Bittinger, S. Healy, J. Alison, E. Kotschet

    
  • ·Basal-Basal Multi Point Pacing (MPP) improves electrical characteristics more than Basal-Apical lead positioning

    Page :S236

    K. Zibell, H. Sugumar, A. Pokawattana, P. Jiampo, L. Odgers, H. Lim, A. Teh, D. O’Donnell

    
  • ·Cardiac device lead extraction in Australia

    Page :S237

    N. Strathmore, P. Brady, R. Denman, R. Giles, J. Hayes, R. Giles, L. Portelli, on behalf of the Lead Extraction Advisory Committee of the CSANZ

    
  • ·Consolidating lesions at sites of critical pulmonary-vein left atrial connections in addition to PVI significantly improves AF-free survival compared to PVI alone

    Page :S237

    S. Kumar, J. Lipton, A. Nisbett, P. Heck, R. Rosso, P. Sparks

    
  • ·Coronary vein collaterals: Implications for Interventional cardiac resynchronisation therapy (CRT)

    Page :S238

    A. Pokawattana, H. Sugumar, P. Jiampo, A. Teh, H. Lim, D. O’Donnell

    
  • ·Could radiofrequency ablations for 180 seconds create transmural ventricular lesions? Results from a myocardial phantom model

    Page :S238

    A. Bhaskaran, W. Chik, M. Farraha, T. Barry, S. Al Raisi, J. Pouliopoulos, C. Nalliah, P. Quan, S. Thomas, P. Kovoor, A. Thiagalingam

    
  • ·Cryoablation of asymptomatic septal accessory pathway(WPW) to achieve resynchronisation to improve left ventricular dysfunction

    Page :S238

    W. Ahmad, B. Bastian, J. Leitch

    
  • ·Do all patients need intense anticoagulation and antiplatelet regimens following WATCHMAN device implantation? A case series of five patients

    Page :S239

    S. Ramkumar, M. Tung, J. Cameron, B. Pang, N. Nerlekar, E. Kotschet, J. Alison

    
  • ·Heparin infusion rather than bolus dosing may be more efficacious for maintaining therapeutic ACT and reducing stroke risk during pulmonary vein isolation ablation procedures for atrial fibrillation

    Page :S239

    S. Thavapalachandran, W. Chik, A. Bhaskaran, S. Kazi, S. Thomas, A. Thiagalingam, P. Kovoor

    
  • ·Isolation of the posterior left atrial wall for patients with persistent atrial fibrillation: Impact of adenosine testing for dormant posterior LA conduction

    Page :S240

    A. McLellan, S. Prabhu, A. Voskoboinik, M. Wong, T. Walters, B. Pathik, G. Morris, A. Nisbet, G. Lee, J. Morton, J. Kalman, P. Kistler

    
  • ·Left atrial surface area remaining not isolated after ablation of persistent atrial fibrillation predicts long-term outcomes

    Page :S240

    C. Nalliah, T. Lim, P. Qian, A. Bhaskaran, R. Kurup, E. Kizana, P. Kovoor, D. Ross, S. Thomas

    
  • ·Left ventricular systolic impairment with right ventricular pacing - how frequently does pacing induced cardiomyopathy occur?

    Page :S240

    J. Ng, S. Ahmed, G. Kaye

    
  • ·Magnetic guidance versus manual control:comparison of radiofrequency lesion dimensions and evaluation of the effect of heart wall motion in a myocardial phantom

    Page :S241

    A. Bhaskaran, T. Barry, S. Al Raisi, W. Chik, D. Nguyen, J. Pouliopoulos, C. Nalliah, R. Hendricks, P. Quan, S. Thomas, A. Mc Evan, P. Kovoor, A. Thiagalingam

    
  • ·Novel technique to implant a transvenous ICD lead through a totally occluded superior vena cava and left subclavian venous system

    Page :S241

    W. Chik, M. Sadek, S. Maeda, J. Pouliopoulos, J. Cooper, F. Marchlinski, R. Schaller

    
  • ·Obesity and atrial fibrillation: electroanatomical left atrial remodelling with pronounced changes adjacent to epicardial fat

    Page :S242

    R. Mahajan, A. Nelson, C. Wong, A. Brooks, R. Pathak, M. Middeldorp, D. Twomey, M. Alasady, A. Carbone, K. Teo, J. Selvanayagam, D. Lau, P. Sanders

    
  • ·Open Ventricular Tachycardia Epicardial Ablation Using Cryoablation and Intraoperative Electroanatomical Mapping via a Minimally Invasive Left Thoracotomy in Hybrid OR

    Page :S242

    W. Chik, P. Santangeli, M. Sadek, S. Maeda, J. Pouliopoulos, N. Desai, G. Supple, F. Marchlinski

    
  • ·Phased radiofrequency ablation (PVAC), for atrial fibrillation – Acute procedural results

    Page :S243

    B. Wilsmore, W. Ahmad, M. Sky, M. Barlow, J. Leitch

    
  • ·Pouches, pectinate & prominent peaks: pitfalls during cavotricuspid isthmus radiofrequency ablation visualised under direct endoscopic visualisation

    Page :S243

    W. Chik, J. Pouliopoulos, A. Bhaskaran, S. Thavapalachandran, D. Ross, S. Thomas, P. Kovoor, A. Thiagalingam

    
  • ·Prevention of inappropriate sensing/therapies by subcutaneous ICD in the setting of unipolar pacing from an abdominal epicardial pacemaker in a patient with mustard atrial switch and unrepaired ventricular septal defect

    Page :S244

    W. Chik, D. Benhayon, M. Sadek, P. Santangeli, S. Maeda, J. Pouliopoulos, D. Frankel, F. Marchlinski

    
  • ·Radiation risk reduction in AF ablation procedures through use of a novel visualisation and navigation system

    Page :S244

    J. Hayes, I. Smith, J. Rivers

    
  • ·Rate dependent conduction block as a marker of incomplete cavotricuspid isthmus ablation

    Page :S245

    P. Kabunga, E. Hodkinson, M. Kilborn

    
  • ·Reduced intensity antiplatelet and anticoagulation regimens post WATCHMAN implant

    Page :S245

    M. Tung, S. Ramkumar, J. Cameron, B. Pang, N. Nerlekar, E. Kotschet, J. Alison

    
  • ·Relationships between anticoagulation regimen, risk score and adverse outcomes in dialysis patients with atrial fibrillation

    Page :S246

    T. Wang, J. Sathananthan, C. Hood, M. Marshall, A. Kerr

    
  • ·Remote day one post implant monitoring of new devices: The MonashHeart experience

    Page :S246

    A. Robertson, V. Mutha, K. Versteege, D. Adam, J. Krafchek, S. Healy, E. Kotschet, J. Alison

    
  • ·Reverse cardiac remodelling following renal denervation - atrial electrophysiologic and structural changes associated with blood pressure lowering

    Page :S247

    A. McLellan, M. Schlaich, A. Taylor, S. Prabhu, D. Hering, L. Hammond, P. Marusic, J. Duval, Y. Sata, A. Ellims, K. Peter, J. Shaw, A. Walton, J. Kalman, P. Kistler

    
  • ·Safety and satisfaction of day case pulmonary vein isolation for atrial fibrillation

    Page :S247

    S. Cheah, D. Adam, E. Kotschet, J. Alison, L. Bittinger, S. Healy

    
  • ·Septal or apical right ventricular pacing lead position - what's the optimal imaging modality - CT, MRI or 3D-echocardiography?

    Page :S248

    P. Moore, C. Booth, J. Coucher, S. Ngai, T. Stanton, S. Wahi, P. Gould, G. Kaye

    
  • ·Significant reduction in radiation exposure with a newer x-ray imaging system in the EP lab

    Page :S248

    A. Lee, J. Crowhurst, H. Haqqani, M. Whitby, R. Denman

    
  • ·Sites of acute and chronic pulmonary vein reconnection can be predicted during the index pulmonary vein isolation for paroxysmal AF

    Page :S249

    S. Kumar, J. Lipton, A. Nisbett, F. Sutherland, P. Heck, R. Rosso, P. Sparks

    
  • ·Temporal stability of rotors and atrial activation patterns in persistent human atrial fibrillation: A high density epicardial mapping study

    Page :S249

    T. Walters, G. Lee, S. Spence, M. Larobina, V. Atkinson, J. Goldblatt, J. Kalman

    
  • ·Temporal stability of the atrial fibrillation cycle length in persistent human atrial fibrillation and its relationship to drivers: a high density epicardial mapping study

    Page :S249

    T. Walters, G. Lee, S. Spence, M. Larobina, V. Atkinson, J. Goldblatt, J. Kalman

    
  • ·Temporal trends in insertion of implantable cardioverter defibrillator from a Victorian regional tertiary centre's perspective

    Page :S250

    H. Thakkar, J. Amerena

    
  • ·The guidance of Cavo-Tricuspid Isthmus ablation using a contact force ablation catheter and novel parameters

    Page :S250

    C. Booth, K. Ng, K. Dauber, G. Kaye, P. Gould

    
  • ·The heterogeneous composition of post-infarct ventricular scar is a critical factor compared to local myocardial volume in influencing the accuracy of electroanatomical voltage mapping

    Page :S251

    R. Samanta, W. Chik, T. Barry, S. Al Raisi, M. Farraha, J. Lu, P. Kovoor, A. Thiagalingam, E. Kizana, J. Pouliopoulos

    
  • ·The role of permanent pacemaker therapy in vasovagal syncope: a systematic review

    Page :S251

    A. Khan, A. Ashraf

    
  • ·The utility of cardiac computer tomography in a case of a pacemaker and dextrocardia

    Page :S252

    B. Pang, H. Mond

    
  • ·Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation: systematic review and meta-analysis

    Page :S252

    K. Phan, C. Medi, T. Yan

    
  • ·Three-dimensional (3D) wavemapping of human persistent atrial fibrillation

    Page :S252

    B. Pathik, T. Walters, G. Morris, J. Morton, J. Kalman, G. Lee

    
  • ·Variation in individual patient electrical characteristics during Multi-Point Pacing (MPP) with Basal - Apical (BA) compared with Basal - Basal (BB) lead positioning

    Page :S253

    K. Zibell, H. Sugumar, A. Pokawattana, P. Jiampo, L. Odgers, H. Lim, A. Teh, D. O’Donnell

    
  • ·Ventricular arrhythmias arising from the septal summit and ablated from the right coronary cusp: anatomical approach to catheter ablation integrating ECG characteristics and intracardiac echocardiography imaging

    Page :S253

    W. Chik, M. Sadek, P. Santangeli, S. Maeda, G. Supple, R. Schaller, D. Schaller, D. Lin, S. Dixit, F. Garcia, D. Callans, F. Marchlinski

    
  • ·When is it necessary to cardiovert a pulmonary vein?

    Page :S254

    M. Wong, J. Kalman

    
  • ·Utility of intravascular ultrasound (IVUS) and its immediate impact on decision making on patients undergoing coronary intervention at a tertiary referral centre

    Page :S254

    S. Mirzaee, E. Sganzerla, S. Weerasooriya, R. Yadav

    
  • ·10-year trends in, and outcomes with, glycoprotein IIb/IIIa inhibitor use in primary PCI in a large Australian multi-centre registry

    Page :S255

    S. Biswas, N. Andrianopoulos, A. Ajani, M. Horrigan, G. New, M. Sebastian, E. Oqueli, D. Clark, C. Reid, D. Eccleston

    
  • ·2-years cost-effectiveness of drug-eluting stents: a Hong Kong perspective

    Page :S255

    B. Yan, L. Chan, V. Lee, C. Yu, C. Reid

    
  • ·30-day Outcomes From The UK Hybrid CTO Registry

    Page :S256

    W. Wilson, S. Walsh, C. Hanratty, H. Douglas, M. McEntegart, K. Oldroyd, A. Bagnall, M. Egred, J. Irving, E. Smith, J. Strange, J. Spratt

    
  • ·A case study on platypnoea-orthodeoxia following abdominal surgery and previous PFO closure

    Page :S256

    D. Barrett, J. Roy, J. Weaver, G. Youssef

    
  • ·A degenerated ASD patch repair successfully re-closed via percutaneous occlusion device

    Page :S257

    E. Wing-Lun, J. Michel, N. Jacobs, D. Roy

    
  • ·A novel risk factor in infarct PCI

    Page :S257

    S. Mylabathula, R. Harjit Singh, J. Lim, D. Cook

    
  • ·A randomised controlled trial of biolimus-eluting and everolimus-eluting stents: An optical coherence tomography (OCT) study

    Page :S258

    U. Hayat, V. Thondapu, E. Poon, A. Incani, C. Raffel, D. Walters, P. Barlis

    
  • ·A systematic review and meta-analysis of clinical and cost-effective outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement

    Page :S258

    C. Cao, S. Virk, K. Liou, F. Pathan, C. Wilcox, E. Novis, T. Yan

    
  • ·Accuracy of the pre-hospital assessment for primary Angioplasty (PAPA) program in the Illawarra region of NSW

    Page :S259

    G. Femia, T. Fetahovik, T. Tiberio, W. Mckenzie, T. Nguyendang, D. Owensby, A. Yeung, P. Shetty, A. Lee

    
  • ·Index

    Page :S259

    
  • ·Adverse outcomes in patients with peripheral vascular disease (PVD) following percutaneous coronary intervention (PCI)

    Page :S259

    J. Ramzy, N. Andrianopoulos, J. Sajeev, L. Roberts, S. Duffy, D. Clark, A. Teh, A. Ajani, C. Reid, E. Oqueli, G. New, M. Freeman

     
  • ·Age is no barrier to transcather aortic-valve replacement

    Page :S260

    E. Shaw, V. Subban, D. Murdoch, M. Savage, J. Crowhurst, C. Raffel, K. Poon, A. Incani, D. Walters

    
  • ·An article on coronary stent deployment by oversizing versus high pressure dilatation: a randomised intravascular ultrasound controlled study

    Page :S260

    E. Zhou, S. Lo, C. Mussap, S. Burgess, C. Juergens

    
  • ·An article on intravascular ultrasound-guided treatment for angiographically equivocal unprotected left main coronary artery disease: an Australian experience

    Page :S261

    E. Zhou, A. Hopkins, S. Lo, C. Juergens

    
  • ·An unusual cause of ST elevation following implantation of a permanent pacemaker

    Page :S261

    P. Qian, Y. Orr, L. Davis

    
  • ·Angina 1 month after percutaneous coronary intervention is associated with increased short-term major adverse cardiac and cerebrovascular events

    Page :S261

    P. Sud, C. Moody, D. Coulshed, D. Parikh, D. Fitzpatrick

    
  • ·Appropriate use of intracoronary GTN in patients with spontaneous spasm helps to avoid unnecessary stenting

    Page :S262

    A. Sheikh, S. Rajendran, D. Difiore, J. Beltrame, C. Zeitz

    
  • ·Assessment of the geometric interaction between the Lotus transcatheter aortic valve prosthesis and the native ventricular aortic interface by 320-multidetector computed tomography

    Page :S262

    R. Gooley, J. Cameron, I. Meredith

    
  • ·Australian multi-centre experience with bioresorbable vascular scaffolds in “real-world” coronary disease - twelve-month outcomes

    Page :S263

    D. Robaei, L. Back, S. Atique, R. Tan, S. Ooi, R. Giles, A. Farshid, M. Pitney, N. Jepson

    
  • ·Balloon aortic valvuloplasty (BAV): Waikato Hospital experience

    Page :S263

    K. Sree Raman, S. Pasupati, R. Nair

    
  • ·Balloon aortic valvuloplasty: contemporary single centre experience in the TAVI era

    Page :S263

    T. Ford, K. Nguyen, M. Pitney, D. Friedman, A. Lau, R. Giles, R. Allan, N. Jepson

    
  • ·Baseline six-minute-walk-test distance predicts functional improvement in patients undergoing transcatheter aortic valve implantation

    Page :S264

    U. Allahwala, K. Herbert, N. Straiton, P. Brady, C. Choong, P. Hansen, R. Bhindi

    
  • ·Bioresorbable scaffold stents, single centre experience

    Page :S264

    K. Haji, R. Dick, L. Baker, S. Waugh

    
  • ·Bleeding risk and choice of arterial access in percutaneous coronary intervention, data from the Victorian cardiac outcomes registry (VCOR)

    Page :S265

    I. Tsay, M. Asrar ul Haq, D. Dinh, A. Brennan, C. Reid, S. Duffy, J. Lefkovits, W. van Gaal

    
  • ·Cardiac catheterisation laboratory complications in an Australian tertiary hospital

    Page :S265

    J. Hanna, A. Erian, H. Donoghue, R. Jayasinghe

    
  • ·Causes of delay in door-to-balloon time in South-east Asian patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

    Page :S266

    M. Tan, A. Ang, E. Sim, K. Quah, P. Ong, D. Foo, H. Ho

    
  • ·Characterisation of neurological injury in the modern era of transcatheter aortic valve implantation (TAVI)

    Page :S266

    J. Fanning, D. Walters, A. Wesley, A. Clarke, C. O'Sullivan, W. Strugnell, J. Fraser

    
  • ·Clinical Outcomes of Percutaneous Interventions in Bypass Grafts

    Page :S267

    R. Parameswaran, V. Gupta, T. David, B. Herman

    
  • ·Clopidogrel vs. Prasugrel vs. Ticagrelor in Patients with Acute Coronary Syndromes (ACS) Treated with Percutaneous Coronary Intervention (PCI)

    Page :S267

    M. Yudi, N. Andrianopoulos, D. Tsang, D. Clark, S. Duffy, A. Brennan, T. Yip, B. Yan, M. Freeman, E. Oqueli, O. Farouque, C. Reid, A. Ajani

    
  • ·Comparative outcome of patients undergoing percutaneous coronary intervention (PCI) following fibrinolysis or primary PCI for ST-elevation myocardial infarction

    Page :S268

    K. Rankin, A. Brennan, N. Andrianopoulos, M. Sebastian, M. Freeman, T. Yip, A. Ajani, D. Clark, C. Reid, J. O’Brien, E. Oqueli, S. Duffy

    
  • ·Comparative Outcomes Following Percutaneous Coronary Intervention (PCI): The Victorian Cardiac Outcomes Registry (VCOR)

    Page :S268

    J. Lefkovits, A. Brennan, D. Dinh, R. Harper, N. Cox, N. Andrianopoulos, V. Nadurata, S. Duffy, D. Clark, C. Reid

    
  • ·Comparing Bleeding and Thromboembolic risk in Double and Triple Anti-platelet/Anti-coagulant Therapy post Percutaneous Coronary Intervention (PCI)

    Page :S269

    S. Teh, B. Qu, L. Roberts, J. Sajeev, J. Ramzy, M. Street, G. New, J. Cooke, M. Freeman, A. Teh

    
  • ·Comparison of the self-expanding CoreValve device and the mechanically expanding Lotus transcatheter aortic valve prosthesis

    Page :S269

    R. Gooley, A. Talman, J. Cameron, S. Lockwood, I. Meredith

    
  • ·Consider the GuideLiner Guide Extension Catheter early for difficult balloon and stent delivery

    Page :S270

    D. Murdoch, R. Gluer, E. Shaw, A. Incani, K. Poon, B. Bell, M. Pincus, A. Mishra, O. Raffel, D. Walters

    
  • ·Contrast fractional flow reserve: a novel screening tool for functional coronary stenosis

    Page :S270

    P. van Wyk, A. Puri

    
  • ·Contrast induced encephalopathy post coronary angiography: a rare case of reversible transient neurotoxicity in the catheter laboratory

    Page :S270

    R. Grover, D. Wynne, B. Gunalingam

    
  • ·Coronary bifurcation lesions: insights from computational fluid dynamics

    Page :S271

    V. Thondapu, E. Poon, U. Hayat, A. Ooi, P. Barlis

    
  • ·Covering your track: IVUS guided covered stent placement at the ostium of LAD after rotablation induced aneurysm

    Page :S271

    J. Antony, D. Murdoch, K. Poon

    
  • ·Current indications and outcomes of intra-aortic balloon counterpulsation: The Liverpool Hospital experience

    Page :S272

    J. Xu, D. Leung, C. Mussap, R. Rajaratnam, T. Naguib Badie, A. Hopkins, J. French, C. Juergens, S. Lo

    
  • ·Differential radiation exposure for gender and age in patients undergoing percutaneous coronary intervention (PCI)

    Page :S272

    A. Rehmani, R. Tan, L. Estomata, L. Divorty

    
  • ·Direct workup for coronary bypass graft surgery rather than attempted angioplasty if CT coronary cacium score over 1500

    Page :S273

    J. England, D. Hammill, L. Davis, N. Patel, J. O’Rourke

    
  • ·Drug-eluting balloon versus second generation drug eluting stents in the treatment of in-stent restenosis: a systematic review and meta-analysis

    Page :S273

    K. Liou, N. Jepson, S. Ooi

    
  • ·Effects of Chronic Kidney Disease (CKD) on patient outcomes following Percutaneous Coronary Intervention (PCI)

    Page :S273

    J. Sajeev, N. Andrianopoulos, J. Ramzy, L. Roberts, S. Duffy, A. Ajani, J. Shaw, D. Clark, C. Hiew, G. New, A. Brennan, M. Freeman, A. Teh, M. Roberts

    
  • ·Evolution of Australian percutaneous coronary intervention: observations from the Melbourne Interventional Group (MIG) registry

    Page :S274

    J. Yeoh, N. Andrianopoulos, V. Chand, B. Yan, D. Clark, S. Duffy, A. Brennan, G. New, D. Eccleston, M. Sebastian, C. Reid, M. Yudi, W. Wilson, A. Ajani

    
  • ·Excessive bleeding with heparin following p-PCI for STEACS and the impact on length of stay of patients

    Page :S275

    F. Ilyas, J. Ngo, R. Tavella, M. Arstall

    
  • ·FFR-guided vs. IVUS-guided vs. Angiography-guided Percutaneous Coronary Intervention in Stable Coronary Artery Disease

    Page :S275

    M. Yudi, N. Andrianopoulos, B. Yan, A. Ajani, A. Brennan, G. New, C. Hiew, K. Charter, A. Al-Fiadh, O. Farouque, D. Clark

    
  • ·Fremantle experience of patients undergoing bioresorbable vascular scaffold implantation

    Page :S276

    A. Rehmani, C. Judkins, S. Atique, T. Nunn, F. Rodrigues, M. Nguyen, A. Whelan

    
  • ·GuideLiner guide extension catheter for difficult coronary intervention: A large, single-centre case series

    Page :S276

    R. Gluer, D. Murdoch, K. Poon, B. Bell, A. Mishra, M. Pincus, O. Raffel, D. Walters

    
  • ·History repeating: A case of recurrent spontaneous coronary artery dissection in different epicardial vessels

    Page :S276

    J. Antony, K. Poon

    
  • ·How should we treat drug eluting stent (DES) instent restenosis (ISR)?

    Page :S277

    J. Shah, M. Sebastian, N. Andrianopoulos, D. Clark, B. Yan, A. Brennan, C. Jaworski, A. Ajani, S. Duffy, G. New, C. Reid, C. Hiew, T. Yip

    
  • ·Hyperacute stent thrombosis after pre-hospital assessment for primary angioplasty (PAPA) ST elevation myocardial infarction

    Page :S277

    G. Femia, T. Fetahovik, T. Tiberio, A. Yeung, A. Lee

    
  • ·Impact of 5F vs. 6F guidecatheter on renal function in CKD with diabetes patients performing PCI through transradial approach

    Page :S278

    C. Kabir, S. Khan

    
  • ·Impact of diabetes mellitus on health status 2 years after PCI

    Page :S278

    B. Yan, L. Chan, V. Lee, C. Yu, C. Reid

    
  • ·Incidence and outcomes of the no-reflow phenomenon during percutaneous coronary intervention: insights from the CADOSA registry

    Page :S279

    E. Ooi, R. Tavella, M. Arstall, D. Chew, M. Worthley, J. Beltrame, C. Zeitz

    
  • ·Increasing radial artery wrist approach to coronary angiography after coronial inquest recommendations following femoral artery deaths

    Page :S279

    J. England, L. Davis

    
  • ·Intracoronary Abciximab to Improve Microvascular Function in Acute Coronary Syndrome Study (INTRACOR)

    Page :S280

    S. Palmer, J. Layland, P. Williams, C. Judkins, A. La Gerche, A. Burns, R. Whitbourn, A. MacIsaac, A. Wilson

    
  • ·Kounis syndrome during coronary angiography at the Gold Coast Hospital

    Page :S280

    L. Guazzo, R. Markham, K. Hyasat, A. Rahman

    
  • ·Long-term outcomes of multivessel intervention versus culprit vessel intervention in ST-segment-elevation myocardial infarction: The Christchurch experience

    Page :S281

    P. van Wyk, D. Smyth, J. Blake, J. Elliott, D. McClean, A. Puri, M. Yi

    
  • ·Long-term safety of an Everolimus-eluting bioresorbable scaffold: two year clinical outcomes in a wide spectrum of coronary lesions

    Page :S281

    D. Robaei, L. Back, S. Ooi, R. Giles, M. Pitney, N. Jepson

    
  • ·Long-term outcomes after percutaneous coronary intervention in Australian private hospitals; results from the National HeartCare group registry

    Page :S282

    D. Eccleston, T. Rafter, A. Whelan, P. Sage, S. Worthley, G. Holt, M. Horrigan

    
  • ·Long-term outcomes of dual vs. triple anti-thrombotic therapy for patients requiring warfarin after coronary artery stenting

    Page :S282

    S. Biswas, J. Lefkovits, M. Horrigan, C. Reid, D. Eccleston

    
  • ·Management of a patient with preserved ejection fraction heart failure with an interatrial shunt device

    Page :S283

    T. Pasley, P. Ruygrok, R. Doughty, I. Gerber

    
  • ·Mediastinal haematoma complicating percutaneous coronary intervention via the radial artery

    Page :S283

    M. Spies, D. Robaei, L. Baker, N. Jepson

    
  • ·Medium-term outcomes after the use of bioresorbable scaffolds for treatment of coronary stenosis in real-world clinical practice: The Christchurch experience

    Page :S284

    T. Hii, D. McClean, A. Puri, J. Blake, J. Elliott, D. Smyth

    
  • ·Medium-term clinical outcomes with transcatheter aortic valve implantation in high-risk patients

    Page :S284

    S. Duffy, R. Sharma, S. Marasco, J. Nathan, R. Dick, A. Walton

    
  • ·Mortality rate and cause of death following Primary Percutaneous Coronary Intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI)

    Page :S285

    A. Doost Hosseiny, S. Moloi, S. Atique, A. Farshid, P. Marley

    
  • ·National multi-centre cost-comparison of trans-catheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) in moderate to high-risk patients with severe symptomatic aortic stenosis in New Zealand (NZ)

    Page :S285

    S. Bhattacharyya, M. Roskruge, K. Sidhu, R. Nair, D. Smyth, M. Webster, P. Ruygrok, J. Ormiston, S. Pasupati

    
  • ·Non-thrombogenic, bioactive stent platform

    Page :S286

    S. Wise, P. Michael, M. Santos, E. Filipe, T. Jeewandara, J. Hung, A. Kondyurin, A. Weiss, M. Bilek, M. Ng

    
  • ·One-shot circumferential renal artery denervation with relative sparing of the arterial wall may be possible using a novel microwave catheter

    Page :S286

    P. Qian, T. Barry, S. Al-Raisi, P. Kovoor, A. McEwan, A. Thiagalingam, S. Thomas

    
  • ·Operator radiation exposure in the cardiac catheterisation laboratory: does biplane angiography increase radiation dose?

    Page :S286

    D. Murdoch, J. Crowhurst, E. Shaw, R. Saireddy, O. Raffel, D. Walters

    
  • ·Optical coherence tomography findings in definite stent thrombosis

    Page :S287

    J. Chan, M. Savage, K. Poon, C. Raffel

    
  • ·Oral anticoagulants in a trauma setting: Cerebral haemorrhage and delayed presentation reversal guidelines: “Time is brain”

    Page :S287

    J. England, L. Davis

    
  • ·Out-of-hospital cardiac arrest: variations in clinical decision making for immediate coronary angiography

    Page :S287

    H. Han, E. Jones, O. Farouque

    
  • ·Outcomes and safety, of a remote “low risk” angioplasty service, commenced in Darwin, Northern Territory, Australia, in March 2014

    Page :S288

    J. Gunton, R. Barthwal, M. Ilton, N. Kangaharan, C. Farquharson, A. Sinhal, J. Vaile, P. Aylward, D. Chew

    
  • ·Outcomes associated with glycoprotein-IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention

    Page :S288

    R. Gellatly, C. Connell, N. Andrianopoulos, A. Ajani, D. Clark, A. Walton, M. Sebastian, A. Brennan, G. New, S. Biswas, S. Nanayakkara, S. Duffy

    
  • ·Outcomes in patients with obstructive sleep apnoea undergoing percutaneous coronary intervention

    Page :S289

    K. Rankin, A. Hutchison, N. Andrianopoulos, C. Machado, S. Duffy, C. Reid, M. Mok, A. Brennan, A. Ajani, D. Clark, M. Freeman, T. Yip, C. Hiew, M. Sebastian

    
  • ·Outcomes of Balloon Aortic Valvuloplasty at a centre with off-site surgical support

    Page :S289

    D. Adikari, D. Yuan, R. Bing, J. Lau, A. Ng, D. Brieger, L. Kritharides, A. Yong

    
  • ·Outcomes of patients undergoing percutaneous coronary intervention following fibrinolysis for ST-elevation myocardial infarction

    Page :S290

    K. Rankin, A. Brennan, N. Andrianopoulos, M. Sebastian, M. Freeman, C. Hiew, A. Ajani, D. Clark, C. Reid, L. Selkrig, C. Machado, S. Duffy

    
  • ·Outcomes of patients with chronic lung disease receiving TAVR in a prospective database

    Page :S290

    J. Chan, K. Poon, M. Savage, J. Crowhurst, V. Subban, D. Murdoch, A. Clarke, C. Raffel, D. Walters

    
  • ·Pain-to-balloon time is a better predictor of adverse outcomes than Door-to-Balloon time in Primary PCI patients

    Page :S291

    A. Doost Hosseiny, A. Farshid, C. Allada, D. McGill, S. O’Connor, A. Rahman, R. Tan, S. Moloi, S. Atique

    
  • ·Percutaneous closure of a large secundum atrial septal defect via the transjugular approach in a patient with an interrupted inferior vena cava

    Page :S291

    S. Zaman, B. Xu, R. Harper

    
  • ·Percutaneous coronary intervention in the very elderly

    Page :S291

    W. Peverill, S. Hayman, A. Brazzale, R. Puchalski, P. Stewart, M. Dooris

    
  • ·Percutaneous patent foramen ovale closure: Long-term procedural experience with three closure devices

    Page :S292

    A. Davies, A. Ekmejian, N. Collins, R. Bhagwandeen

    
  • ·Perforation of the left ventricle during routine left ventriculography

    Page :S292

    M. Yudi, B. Herman

    
  • ·Peripheral access site vascular complications in Transcatheter Aortic-Valve Replacement (TAVR)

    Page :S292

    E. Shaw, V. Tan, D. Murdoch, V. Subban, M. Savage, J. Crowhurst, K. Poon, A. Incani, C. Raffel, D. Walters

    
  • ·Peri-procedural myocardial injury and long-term mortality in percutaneous coronary intervention for stable coronary artery disease

    Page :S293

    C. Goh, M. Yudi, K. Lu, A. Al-Fiadh, M. Mok, D. Clark, O. Farouque

    
  • ·Pre-hospital assessment for Primary Angioplasty (PAPA) reduces reperfusion times in ST Elevation Myocardial Infarction (STEMI) - A report from the Hunter New England Local Health District

    Page :S293

    A. Rajaratnam, M. Kwa, P. Ryan, S. Phillips, E. Pither, L. Parsonage, A. Boyle

    
  • ·Pre-procedural fasting for patients undergoing percutaneous coronary interventions: A survey of interventional cardiologists’ practice preferences

    Page :S294

    J. Rolley, L. Kuhn, D. Berry, A. Hutchinson, M. Botti, J. Considine

    
  • ·Pre-procedural fasting for patients undergoing percutaneous coronary interventions: Preliminary results from a multi-centre retrospective audit

    Page :S294

    J. Rolley, L. Kuhn, D. Berry, A. Hutchinson, M. Botti, J. Considine

    
  • ·Primary Percutaneous Coronary Intervention (PPCI) in Octogenarians: Clinical characteristics and outcomes in a regional setting

    Page :S295

    S. Hayman, Y. Chako, K. Lau, S. Butterly, A. Willson, P. Larsen, R. Poulter, D. Colburn, C. Thompon, M. Johnson

    
  • ·Prolonged infusion of bivalirudin improves outcomes in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomised trials

    Page :S295

    V. Nagaraja, K. Liou, N. Jepson, G. Eslick, S. Ooi

    
  • ·Radial artery patency after trans-radial cardiac catheterisation in a Bangladeshi population

    Page :S296

    M. Zia Chowdhury, C. Kabir, M. Haq

    
  • ·Raised Neutrophil-Lymphocyte Ratio following acute STEMI is associated with increased rates of Re-infarction and Mortality at 1 year

    Page :S296

    J. Mau, M. Itchins, A. Davis, J. Offord, S. Soo Hoo, S. Clarke, G. Figtree, R. Bhindi, P. Hansen, H. Rasmussen, G. Nelson, M. Ward

    
  • ·Rare complication of a saphenous vein graft aneurysm: A Case Report

    Page :S296

    T. Hii, A. Puri, P. Van Wyk, I. Crozier, D. Smyth

    
  • ·Regional systems of care to optimise outcomes in patients undergoing transcatheter aortic valve implantation (TAVI)

    Page :S297

    D. Stub, S. Lauck, M. Lee, M. Gao, A. Chan, A. Della Siega, S. Robinson, D. Wong, J. Ye, A. Cheung, D. Wood, J. Webb

    
  • ·Reliability of thermodilution derived cardiac output with different operator characteristics

    Page :S297

    S. McKenzie, C. Anstey, G. Javorsky, D. Platts, S. Gregory, W. Chan

    
  • ·Removing the Antiscatter Grid: A simple way to lower radiation during both Angiography and PCI

    Page :S298

    J. Roy, J. Weaver, M. Sader, G. Ison

    
  • ·Resuscitated out-of-hospital cardiac arrest: predictors of in-hospital survival

    Page :S298

    H. Han, F. Djukiadmodjo, A. Al-Fiadh, K. Sanders, P. Scott, A. Teh, H. Lim, D. O’Donnell, E. Jones, O. Farouque

    
  • ·Right heart catheterisation via antecubital venous access: a promising technique

    Page :S298

    V. Gupta, R. Parameswaran, W. Noor, I. Ullah, B. Herman

    
  • ·Role of CHA2DS2-VASc score in Evaluating patients with Atrial Fibrillation(AF) undergoing Percutaneous Coronary Intervention(PCI)

    Page :S299

    M. Freeman, N. Andrianopoulos, L. Roberts, S. Duffy, A. Brennan, D. Clark, A. Ajani, C. Reid, T. Yip, E. Oqueli, G. New, A. Teh

    
  • ·Rotablation to treat heavily calcified coronary vessels in a patient with significant co-morbidities

    Page :S300

    D. Chee

    
  • ·Routine debulking rotational atherectomy preparation before drug eluting balloons for the management of in-stent restenosis

    Page :S300

    D. Vickers, D. Robaei, A. Carlyle, A. Lau, R. Giles, S. Ooi, M. Pitney, N. Jepson

    
  • ·Safety and efficacy of transcatheter aortic valve implantation compared with surgical aortic valve replacement in older high-risk patients with severe aortic stenosis - a single centre study

    Page :S300

    V. Wilson, T. Wong, P. Tamuno, S. Pasupati, R. Nair

    
  • ·Should P2Y12 inhibitors be administered empirically in Non-ST-Elevation Acute Coronary Syndrome management prior to coronary angiography? A decision-making analysis into the value of pre-treatment

    Page :S301

    J. Gunton, T. Hartshorne, A. Chuang, D. Chew

    
  • ·Simple vs. complex coronary intervention: impact on radiation exposure to the patient and operator

    Page :S301

    J. Crowhurst, M. Whitby, D. Murdoch, C. Raffel, A. Lee, E. Shaw, D. Walters

    
  • ·Single Centre Results of First 100 Patients Treated with the Absorb Bioresorbable Vascular Scaffold

    Page :S302

    W. Jaffe

    
  • ·Six years of transcatheter aortic valve implantation (TAVI) in Waikato

    Page :S302

    S. Pasupati, A. El Gamel, J. Lau, M. Davis, G. Devlin, N. Kejriwal, B. Chan, R. Fisher, S. Govender, C. Sebastian, R. Nair

    
  • ·SOLACE AU Registry: Interim results at 30 days of the Edwards SAPIEN XT ™ Transcatheter Heart Valve in intermediate risk patients with severe aortic stenosis in Australia

    Page :S302

    D. Walters, A. Sinhal, M. Ng, G. Yong, N. Jepson, S. Worthley, R. Gurvitch, A. Walton, R. Bindi, R. Whitbourn

    
  • ·Stenotic flow reserve assessed on quantitative coronary angiography has modest but incremental value in predicting functionally significant coronary stenosis as evaluated by fractional flow reserve

    Page :S303

    E. Potter, C. Machado, J. Cameron, I. Meredith, Y. Malaiapan, D. Wong

    
  • ·Stent thrombosis incidence in a quaternary Australian centre

    Page :S303

    J. Chan, S. Yong, K. Poon, M. Savage, B. Bell, D. Murdoch, D. Walters, C. Raffel

    
  • ·Successful palliative valvuloplasty for critical aortic valve stenosis in aspartylglucosaminuria (AGU) syndrome

    Page :S304

    S. Buchholz, R. Schrale, M. Zhang

    
  • ·Sustained quality-of-life benefits up to 2-years after percutaneous coronary intervention for chronic total occlusions

    Page :S304

    B. Yan, L. Chan, V. Lee, C. Yu, C. Reid

    
  • ·Systematic review of percutaneous coronary intervention and transcatheter aortic valve implantation for concomitant aortic stenosis and coronary artery disease

    Page :S305

    S. Virk, D. Tian, K. Liou, F. Pathan, E. Novis, C. Wilcox, C. Cao

    
  • ·Temporal trends and indications for the use of IVUS and FFR to guide PCI in contemporary practice

    Page :S305

    M. Yudi, N. Andrianopoulos, B. Chan, A. Ajani, A. Brennan, S. Duffy, G. New, C. Hiew, K. Charter, A. Al-Fiadh, O. Farouque, D. Clark

    
  • ·The 123s and ABCs of the simplified SYNTAX score

    Page :S306

    R. Bing, J. Zhao, S. Papapostolou, S. Burgess, E. Danson, R. Bhindi, S. Lo, W. Chan, M. Ng, L. Kritharides, A. Yong

    
  • ·The CRUSADE score is useful in stratifying risk of major bleeding and death following STEMI PCI

    Page :S306

    S. Atique, C. Schultz, J. Rankin, M. Knuiman, M. Nguyen, M. Newman, D. Cutlip, T. Briffa, M. Hobbs, E. Geelhoed, F. Sanfilippo

    
  • ·The effects of Abciximab on microcirculatory dysfunction in acute coronary syndrome

    Page :S307

    M. Ng, G. Martínez, H. Jangwal

    
  • ·The index of microcirculatory resistance post percutaneous coronary intervention predicts left ventricular recovery in patients with thrombolysed ST-segment elevation myocardial infarction

    Page :S307

    S. Palmer, J. Layland, R. McGeoch, D. Carrick, P. Williams, C. Judkins, F. Gong, B. Flaim, A. Burns, R. Whitbourn, A. MacIsaac, C. Berry, K. Oldroyd, A. Wilson

    
  • ·The resistive reserve ratio predicts acute infarct characteristics in patients with STEMI

    Page :S308

    J. Layland, D. Carrick, N. Nerlekar, N. Ahmed, M. Lindsay, K. Oldroyd, C. Berry

    
  • ·The safety of rotational atherectomy at a PCI capable centre with no on-site cardiac surgery

    Page :S308

    S. Kyranis, M. Dooris, G. Katahanas, P. Stewart

    
  • ·The unfortunate case of multiple complications from TAVI

    Page :S308

    D. Chee, N. Nerlekar

    
  • ·The use of patient radiation dose as a metric for advanced trainee performance of diagnostic coronary angiographic procedures

    Page :S309

    A. Westerink, M. Dooris

    
  • ·Tornus catheter for calcified coronary stenoses that cannot be crossed with other devices

    Page :S309

    B. Jahangiri, D. Murdoch, C. Raffel, A. Incani, K. Poon, B. Bell, M. Pincus, A. Mishra, M. Savage, D. Walters

    
  • ·Transcatheter aortic valve implantation - the St Vincent's Hospital (Melbourne) experience

    Page :S310

    S. Palmer, Y. Chanwahhak, C. Wright, C. Perrins, I. Zweng, A. Wilson, P. Davis, A. MacIsaac, A. Newcomb, R. Whitbourn

    
  • ·Index

    Page :S310

    
  • ·Transcatheter aortic-valve replacement - is there a sex difference?

    Page :S310

    E. Shaw, D. Murdoch, V. Subban, M. Savage, J. Crowhurst, K. Poon, A. Incani, C. Raffel, D. Walters

    
  • ·Trans-radial versus femoral artery access for percutaneous coronary intervention in acute coronary syndrome: A reflection from a five-year experience in the MIG cohort

    Page :S311

    K. Rankin, C. Machado, N. Andrianopoulos, T. Yip, E. Oqueli, C. Jaworski, D. Clark, G. New, M. Mok, A. Ajani, C. Hiew, M. Sebastian

    
  • ·Trans-radial vs.trans-femoral radiation exposure and screening times for diagnostic coronary angiography at Sydney Southwest Private Hospital

    Page :S311

    M. De Raya, J. Holden, O. Wayman, D. Taylor

    
  • ·Trends, clinical characteristics and outcomes of patients undergoing FFR-guided management in a real world cohort

    Page :S311

    O. Wahbi-Izzettin, M. Yudi, D. Russell, P. MacIntyre, L. Galligan, P. Roberts-Thomson, N. Dwyer, A. Black

    
  • ·Use of fractional flow reserve (FFR) in the assessment of coronary artery disease leads to reduction of percutaneous coronary intervention (PCI) patients

    Page :S312

    M. De Raya, J. Holden, O. Wayman, D. Taylor

    
  • ·Utility of a new regional cardiac catheterisation laboratory

    Page :S312

    Y. Chacko, S. Hayman, A. Willson, S. Butterly, P. Larsen, R. Poulter, C. Thompson, D. Colburn, K. Lau, M. Johnson

    
  • ·Utility of the ACC/AHA lesion classification in the modern era of percutaneous coronary intervention

    Page :S313

    P. Scott, M. Yudi, O. Farouque, D. Fernando, M. Horrigan, A. Al-Fiadh, K. Charter, J. Ramchand, A. Brennan, N. Andrianopoulos, S. Duffy, A. Ajani, D. Clark

    
  • ·Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) after intra-aortic balloon pump (IABP) Counterpulsation: The Liverpool Hospital experience

    Page :S313

    J. Xu, A. Hopkins, R. Rajaratnam, T. Naguib Badie, D. Taylor, D. Leung, C. Juergens, S. Lo

    
  • ·‘Malignant” anomalous origin of the right coronary artery (MRCA) from the left Sinus of Valsalva with an inter-arterial course

    Page :S315

    J. Latona, A. Khan, A. Rahman

    
  • ·A case of a thrombus trapped in a patent foramen ovale

    Page :S315

    P. Chandrala, K. Johnson, H. Hallani

    
  • ·A comprehensive radiation risk management program in cardiac imaging

    Page :S316

    J. Rivers, J. Cameron, I. Smith, A. Wallace, L. Wilkinson

    
  • ·A large venous thromboembolus caught by the Eustachian valve prevents massive pulmonary embolism

    Page :S316

    E. Wing-Lun, A. Omari, R. Subbiah, M. Feneley

    
  • ·A mediastinal mass following coronary artery bypass surgery

    Page :S317

    G. Wong, S. Parvar, A. Rajwani, K. Williams, D. Scherer, R. Roberts-Thomson, A. Nelson, M. Shirazi, S. Worthley, K. Teo

    
  • ·A novel insight into rapid changes in trans-pulmonary haemodynamic status pre- and post-Amplatzer atrial septal defect closure using the novel non-invasive parameter, “ePLAR”

    Page :S317

    A. Kwon, M. Tran, N. Edwards, G. Scalia

    
  • ·A novel non-invasive pulmonary vasoreactive challenge utilising cardiac magnetic resonance imaging: comparison of subjects with and without pulmonary arterial hypertension

    Page :S318

    T. Baillie, K. Teo, S. Sidharta, S. Worthley, P. Sanders, P. Steele, S. Nicholls, M. Worthley

    
  • ·A novel non-invasive pulmonary vasoreactivity protocol utilising cardiac magnetic resonance imaging in patients with known or suspected pulmonary arterial hypertension (PAH)

    Page :S318

    T. Baillie, P. Steele, S. Nicholls, K. Teo, S. Sidharta, S. Worthley, P. Sanders, M. Worthley

    
  • ·A patient with severe aortic stenosis masquerading as heart failure

    Page :S319

    S. Trivedi, J. England, C. Hsu, P. Kovoor, L. Davis

    
  • ·A ring in the heart - Ebstein's anomaly and a blood cyst

    Page :S319

    R. Maxwell, C. Hamilton-Craig, T. Butler, D. Wall, M. Ischenko

    
  • ·Accuracy of an operator-independent left ventricular ejection fraction quantification algorithm (Auto LVQ) with three-dimensional echocardiography: a comparison with cardiac magnetic resonance imaging

    Page :S319

    K. Guppy-Coles, S. Prasad, S. Hillier, K. Smith, A. Lo, J. Sippel, N. Biswas, A. Dahiya, J. Atherton

    
  • ·Acute ST-elevation myocardial infarction resulting from sclerotherapy

    Page :S320

    E. Shaw, M. Ward, C. Choong, H. Washington

    
  • ·Adverse diastolic remodelling predicts scar size and adverse cardiovascular outcomes after acute myocardial infarction

    Page :S320

    T. Nguyen, J. Phan, J. Hogan, L. Hee, D. Moses, J. Otton, U. Premawardhana, R. Rajaratnam, C. Juergens, H. Dimitri, J. French, D. Richards, L. Thomas

    
  • ·An article on cardiac heart disease and value of echocardiography

    Page :S321

    A. Dashwood, M. Pavicic, A. Rahman

    
  • ·An article on the relationship between epicardial fat and quantitative coronary artery plaque progression: Insights from cardiac computed tomography angiography

    Page :S321

    P. Psaltis, A. Talman, K. Munnur, J. Cameron, B. Ko, I. Meredith, S. Seneviratne, D. Wong

    
  • ·An audit of transthoracic echocardiograms at Timaru Public Hospital

    Page :S321

    M. Makary, B. Kuepper

    
  • ·An unusual cause of angina

    Page :S322

    S. Parvar, G. Wong, K. Williams, J. Edwards, L. Samaraie, P. Disney, M. Brown, S. Worthley, K. Teo

    
  • ·Aortic root measurements on cardiac CT - are the echocardiographic reference ranges applicable?

    Page :S322

    J. Yeoh, M. Zallmann, S. Wein, E. Lui, S. Heinze, R. Gurvitch, J. Wong, A. Aggarwal, S. Joshi

    
  • ·Aortic valve orientation and root angles are associated with aortic dilatation patterns: Comparative study between BAV and TAV

    Page :S322

    A. Hardikar, A. Iannaconne, R. Harle, T. Marwick

    
  • ·Apical hypertrophic cardiomyopathy with coronary artery disease

    Page :S323

    S. Thavapalachandran, D. Wong, M. Mardini, T. Tan

    
  • ·Application of the 2011 Appropriateness Criteria for Echocardiography to characterise inpatient referral patterns in a large tertiary metropolitan hospital

    Page :S323

    P. Brown, T. Tan

    
  • ·Appropriate use criteria and CTCA - is there a role in asymptomatic individuals?

    Page :S324

    J. Vazirani, J. Liu, N. Better, S. Heinze, P. Einsiedel, F. Langenberg, D. Eccleston, S. Joshi

    
  • ·Appropriateness of transthoracic echocardiography use in an Australian regional centre

    Page :S324

    A. Al-Kaisey, E. Jones, V. Nadurata, O. Farouque, D. De Silva, J. Ramchand

    
  • ·Are all heart failure risk factors equal? Comparison of myocardial dysfunction late after chemotherapy with other stage a heart failure in community patients

    Page :S324

    M. Nolan, Y. Wang, H. Yang, T. Marwick

    
  • ·Assessing endothelial function in type-2-diabetes using a novel method of ECG-gated retinal artery flicker provocation and digital reactive hyperaemia (Endopat®)

    Page :S325

    A. Lal, S. Kazi, P. Kovoor, G. Liew, P. Mitchell, A. Thiagalingam

    
  • ·Assessment of pre-test algorithms to predict CAD by CTCA in emergency department chest pain

    Page :S325

    A. He, J. Neill, B. Bell, D. Walters, J. Chan, K. Branch, C. Hamilton-Craig

    
  • ·Association between left ventricular global longitudinal strain, functional capacity and quality of life in patients with chronic kidney disease

    Page :S326

    T. Stanton, R. Krishnasamy, C. Hawley, E. Howden, K. Beetham, H. Strand, R. Leano, B. Haluska, J. Coombes, N. Isbel

    
  • ·Atherosclerotic plaque on CTCA and medication use

    Page :S326

    J. Vazirani, J. Liu, N. Better, S. Heinze, C. Hacking, P. Einsiedel, F. Langenberg, S. Joshi

    
  • ·Baseline RV function is a stronger predictor of response to vasodilators in pulmonary hypertension than six-minute walk

    Page :S327

    L. Wright, K. Negishi, N. Dwyer, T. Marwick

    
  • ·Cardiac magnetic resonance imaging: a valuable tool in the investigation of troponin positive acute coronary syndromes without identifiable culprit lesions at coronary angiography

    Page :S327

    C. Luis, S. Luis, M. Habibian, M. Lwin, W. Strugnell, M. Savage, R. Slaughter, J. Chan, C. Hamilton-Craig, O. Raffel

    
  • ·Cardiac MRI demonstrates increased pericardial effusions and subclinical myocardial inflammation, as a potential cause for cardiac dysfunction in a contemporary cohort of patients with HIV

    Page :S328

    E. O’Dwyer, N. Ntusi, L. Dorrell, E. Wainwright, C. Holloway, S. Piechnik, G. Clutton, G. Hancock, V. Ferrier, P. Cox, M. Badri, T. Karamitos, K. Clarke, S. Neubauer

    
  • ·Cardiac Myxoma: An unusual presentation

    Page :S328

    S. Thavapalachandran, N. Stewart, A. Kotlar, T. Tan, M. Skinner

    
  • ·Cardiac vignette: A curious case of left ventricular hypertrophy

    Page :S329

    A. Bhat, G. Gan, F. Fernandez, A. Denniss

    
  • ·Cardiac vignette: An interesting case of concurrent hypertrophic obstructive cardiomyopathy (HOCM) and takotsubo cardiomyopathy (TCM)

    Page :S329

    G. Gan, A. Bhat, M. Stevens, F. Fernandez, N. Sadick

    
  • ·Cardiac vignette: Giant left ventricular aneurysm in the setting of emergent transmural ischaemia

    Page :S330

    A. Bhat, G. Gan, B. Khoury, F. Fernandez

    
  • ·Cardiac vignette: Isolated case of right ventricular non-compaction

    Page :S330

    A. Bhat, G. Gan, F. Fernandez, A. Denniss

    
  • ·Characteristics of plaque microstructures in diabetic patients receiving metformin: frequency domain optical coherence tomography analysis

    Page :S331

    D. Scherer, Y. Kataoka, A. Pisaniello, K. Uno, R. Puri, E. Tuzcu, S. Nissen, S. Nicholls

    
  • ·Comparison of left atrial area with left atrial volume index in the echocardiographic assessment of left atrial size

    Page :S331

    J. Chong, L. Wishart, M. Zanoni, S. Young, A. Soward, D. Wong

    
  • ·Comparison of radiation doses between coronary CT and catheter coronary angiography: an update

    Page :S332

    K. Leong, J. Vazirani, P. Einsiedel, C. Hacking, N. Better, R. Gurvitch, C. Neal, D. Ecclestone, F. Langenberg, E. Lui, S. Joshi

    
  • ·Computed tomography coronary angiography can accurately quantify coronary luminal area and plaque volume compared to invasive intravascular ultrasound

    Page :S332

    R. Munnur, J. Andrews, S. Nicholls, Y. Kataoka, Y. Malaiapan, B. Ko, J. Cameron, I. Meredith, S. Seneviratne, D. Wong

    
  • ·Coronary graft aneurysm causing dynamic pulmonary artery compression

    Page :S332

    S. Gutman, J. Gutman, D. Mooney, J. Vrazas

    
  • ·Correlation of coronary and aortic atherosclerosis by computed tomographic coronary angiography

    Page :S333

    G. Guduguntla, C. Yu, L. Bank, A. Lau

    
  • ·Decreased myocardial strain is associated with acute inflammatory changes detected on cardiac magnetic resonance imaging in patients with myocarditis and normal LVEF

    Page :S333

    G. Gan, A. Bhat, C. Hsu, T. Tan

    
  • ·Determining the role of pre-operative investigations in predicting adverse outcomes from bariatric surgery

    Page :S334

    A. Pathmanathan, D. Playford, A. Ahmadi, H. Chandraratna, A. Didan, M. Bulsara

    
  • ·Diagnostic accuracy of semi-automated transluminal attenuation gradient (2nd-Generation-TAG320) on CT coronary angiography for identification of functionally significant coronary artery stenosis: a comparison with Fractional Flow Reserve (FFR)

    Page :S334

    D. Wong, B. Ko, J. Cameron, D. Leong, N. Nerlekar, M. Leung, P. Psaltis, Y. Malaiapan, I. Meredith, S. Seneviratne

    
  • ·Diagnostic performance of transluminal attenuation gradient and non-invasive fractional flow reserve derived from 320 detector computed tomography angiography to diagnose haemodynamically significant coronary stenosis- a NXT substudy

    Page :S334

    B. Ko, D. Wong, B. Norgaard, D. Leong, J. Cameron, S. Gaur, M. Marwan, S. Achenbach, S. Kuribayashi, T. Kimura, I. Meredith, S. Seneviratne

    
  • ·Differential involvement of left ventricular myocardial fibres in aortic stenosis is related to severity

    Page :S335

    M. Fung, L. Thomas, C. Said, D. Leung

    
  • ·Differential recovery of myocardial systolic global strain after STEMI

    Page :S335

    L. Hee, A. Chen, C. Mussap, T. Nguyen, C. Juergens, H. Dimitri, J. French, D. Richards, L. Thomas

    
  • ·Discordance in left atrial grading classifications between left atrial area and left atrial indexed volume calculations: impact of new guidelines on chamber quantification

    Page :S336

    K. Guppy-Coles, A. McDonald, L. White, A. Lo, J. Atherton, S. Prasad

    
  • ·Discriminating between severe and intermediate stenoses on computed tomography coronary angiography (CTCA) using changes in contrast intensity

    Page :S336

    C. Yu, P. Symmonds, J. Otton, D. Boshell, B. Milner, E. Hsu, J. McCrohon, N. Sammel, A. Jabbour, M. Feneley

    
  • ·Early changes in diastolic function following anthracycline chemotherapy for breast cancer

    Page :S337

    P. Stoodley, A. Boyd, K. Vo, D. Richards, L. Thomas

    
  • ·Echocardiographic measures of ventricular function as predictors of recurrence of atrial fibrillation following electrical cardioversion

    Page :S337

    G. Gan, A. Bhat, T. Suo, M. Stevens, F. Fernandez, A. Denniss, T. Tan

    
  • ·Echocardiography remains a key investigation in assessment of pulmonary embolism severity

    Page :S338

    E. Paratz, W. Cui, W. Yeh, T. Roberts

    
  • ·Echocardiography service provision in New Zealand: Capacity modelling the cardiac sonographer workforce

    Page :S338

    B. Buckley, M. Farnworth, G. Whalley

    
  • ·Effect of individual high-intensity statin agents on optical coherence tomography derived measures of plaque stability

    Page :S338

    Y. Kataoka, D. Scherer, A. Pisaniello, K. Uno, R. Puri, E. Tuzcu, S. Nissen, S. Nicholls

    
  • ·Effect of weight loss and risk factor management on pericardial fat and cardiac structure in-patients with atrial fibrillation

    Page :S339

    R. Pathak, A. Nelson, M. Meredith, A. Carbone, A. Mehta, K. Teo, K. Williams, R. Mahajan, D. Twomey, D. Lau, W. Abhayaratna, P. Sanders

    
  • ·Effects of changes in estimated left ventricular filling pressure on functional and structural reverse remodelling of the left atrium

    Page :S339

    Q. Huynh, K. Kalam, A. Iannaccone, K. Negishi, L. Thomas, T. Marwick

    
  • ·Endocarditis and transoesophageal echocardiography - the Wollongong Hospital experience

    Page :S340

    T. Fetahovic, G. Femia, A. Tiberio, T. Nguyen-Dang, A. Yeung, P. Shetty, A. Lee

    
  • ·Epicardial fat measured by computed tomography coronary angiography is associated with significant coronary stenosis independent of traditional risk factors

    Page :S340

    E. Potter, R. Muthalaly, A. Talman, P. Psaltis, B. Ko, J. Cameron, I. Meredith, S. Seneviratne, D. Wong

    
  • ·ePLAR - The echocardiographic pulmonary to left atrial ratio - a novel non-invasive parameter to differentiate pre-capillary and post-capillary pulmonary hypertension

    Page :S341

    G. Scalia, I. Scalia, R. Kierle, R. Beaumont, D. Cross, J. Feenstra, D. Burstow, B. Fitzgerald, D. Platts

    
  • ·ePLAR: the echocardiographic pulmonary to left atrial ratio - conceptualising a new parameter for the assessment of pulmonary hypertension. Foundation data from 16,356 normal echocardiograms

    Page :S341

    G. Scalia, I. Scalia, B. Fitzgerald, D. Burstow, D. Platts

    
  • ·Exercise training in pulmonary hypertension - a pilot study using ultra-fast cine cardiac magnetic resonance imaging

    Page :S342

    A. Lin, H. Seale, A. Trotter, W. Strugnell, F. Kermeen, C. Hamilton-Craig, B. Schmitt, M. Zenge, M. Schmidt

    
  • ·Feasibility of supine bicycle exercise echocardiography for the investigation of unexplained exertional dyspnoea

    Page :S342

    A. Dahiya, C. Booth, A. Lo, K. Smith, S. Prasad, J. Younger, J. Atherton, C. Zappala

    
  • ·Genesis of clinical quality activities within a national echocardiography database: observations from the Heartcare group registry

    Page :S343

    D. Eccleston, D. Cehic, H. Mohammed, D. Cross

    
  • ·Growth and geographical variation in the use of cardiac imaging may reflect ineffective utilisation

    Page :S343

    R. Fonseca, P. Otahal, N. Wiggins, T. Marwick

    
  • ·Heart rate and height should both be considered when interpreting the left ventricular long axis peak systolic velocity

    Page :S344

    R. Peverill, L. Donelan, B. Chou

    
  • ·Imaging the left atrial appendage in atrial fibrillation: comparison of transoesophageal echocardiography with computed tomography

    Page :S344

    M. Kok, J. Cameron, A. Japp, P. Mottram

    
  • ·Impaired myocardial oxygenation response to stress in patients with chronic kidney disease

    Page :S344

    S. Parnham, J. Gleadle, S. Bangalore, S. Grover, R. Perry, R. Woodman, C. De Pasquale, J. Selvanayagam

    
  • ·Incidence and predictors of left ventricular thrombus following STEMI: A cardiac MRI study

    Page :S345

    J. Phan, T. Nguyen, D. Moses, U. Premawardhana, C. Juergens, R. Rajaratnam, H. Dimitri, J. French, D. Richards, L. Thomas

    
  • ·Independent association of right ventricular strain with functional capacity in pulmonary arterial hypertension

    Page :S345

    L. Wright, K. Negishi, N. Dwyer, T. Marwick

    
  • ·Influence of heart rate correction on guideline-driven classification of valvular aortic stenosis.

    Page :S346

    S. Tatavarti, H. Raghuraman, S. Buchholz

    
  • ·Initial experience with semi-supine bicycle stress echocardiography in a regional setting

    Page :S346

    S. Buchholz, B. Bolbol, K. Somaratna, M. Zhang

    
  • ·Is bicuspid aortic valve phenotype heterogeneity predicting aortopathy or accelerated valve dysfunction?

    Page :S347

    M. Habibian, A. Yedalian, H. Raghuraman, M. Zhang, S. Buchholz

    
  • ·Is computed tomography coronary angiography (CTCA) more likely than myocardial perfusion scintigraphy (MPS) to alter primary prevention therapies in patients presenting at intermediate risk of coronary artery disease

    Page :S347

    I. Tsay, I. Subiakto, A. Castles, M. Asrar ul Haq, W. van Gaal

    
  • ·Is global longitudinal strain better than left ventricular ejection fraction for predicting infarct scar size?

    Page :S347

    L. Hee, A. Chen, C. Mussap, T. Nguyen, C. Juergens, H. Dimitri, J. French, D. Richards, L. Thomas

    
  • ·Is Three-dimensional strain better than two-dimensional strain?

    Page :S348

    K. Negishi, H. Yang, Y. Wang, M. Nolan, M. Saito, T. Negishi, T. Marwick

    
  • ·Iterative Model Reconstruction (IMR) improves image quality and diagnostic performance in prospective ECG-Gated coronary CT Angiography (CTCA)

    Page :S348

    L. Carr, M. Balcerek, P. Challa, A. Dahiya

    
  • ·Large apical thrombus due to Takotsubo cardiomyopathy

    Page :S349

    G. Wong, S. Parvar, A. Rajwani, K. Williams, D. Scherer, A. Pisaniello, R. Roberts-Thomson, M. Shirazi, M. Brown, S. Worthley, K. Teo

    
  • ·Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death

    Page :S349

    J. Nadel, T. Lancefield, A. Voskoboinik, A. Taylor

    
  • ·Left atrial strain an earlier marker than NT pro BNP to assess cardiac involvement in CKD

    Page :S350

    K. Kadappu, L. Cai, D. Thomas, J. French, L. Thomas

    
  • ·Medical student performed pocket-sized ultrasound echocardiography after brief training compared to physical examination to detect significant valvular heart disease: a medical student project

    Page :S350

    B. Yan, H. Wong, J. Fok, W. Cheung, T. Kwan, V. Tan, K. Chui, K. Kam, A. Lee

    
  • ·Methods and applications for cardiovascular 3D-printing

    Page :S351

    J. Otton, G. Schlaphoff

    
  • ·Mobile left ventricular pendunculated fungal mass

    Page :S351

    S. Thavapalachandran, P. Brown, T. Tan

    
  • ·MR conditional pacemaker - An initial CMR experience

    Page :S351

    G. Wong, S. Parvar, K. Williams, A. Rajwani, D. Scherer, R. Roberts-Thomson, A. Nelson, M. Brown, G. Young, P. Sanders, S. Worthley, K. Teo

    
  • ·Myocardial blood flow assessment in cardiac amyloidosis using myocardial contrast echocardiography

    Page :S352

    M. Nam, K. Nel, S. Hayman, Y. Chacko, K. Lau, R. Senior, K. Greaves

    
  • ·Myocardial injury following blunt chest trauma as Evaluated by Cardiac MRI: a prospective, cohort study

    Page :S352

    A. Burrell, J. Hare, M. Fitzgerald, D. Cooper, D. Kaye, A. Taylor

    
  • ·Myocardial perfusion is impaired in renal and liver transplant recipients: a cardiovascular magnetic resonance imaging study

    Page :S353

    S. Parnham, J. Gleadle, D. Leong, S. Grover, C. Bradbrook, R. Woodman, C. De Pasquale, J. Selvanayagam

    
  • ·Non-invasive assessment of effect of exercise on Pulmonary artery systolic pressure in healthy subjects

    Page :S353

    A. Khan, S. Turner, L. Quiqueree, S. Meakes

    
  • ·Novel activated platelet targeted theranostic microbubbles for simultaneous diagnosis and treatment of thrombosis via ultrasound

    Page :S353

    X. Wang, Y. Gkanatsas, J. Palasubramaniam, J. Hohmann, C. Hagemeyer, K. Peter

    
  • ·Optical coherence tomography for serial in vivo imaging of aortic plaque in the rabbit

    Page :S354

    J. Fulcher, S. Patel, S. Nicholls, S. Bao, D. Celermajer

    
  • ·Optical super resolution imaging of cardiac myocyte excitation contraction structures

    Page :S354

    Y. Hou, I. Jayasinghe, D. Crossman, D. Baddeley, C. Soeller

    
  • ·Pathophysiological features of non-ischaemic stage B heart failure are determined by the underlying aetiology

    Page :S355

    H. Yang, K. Negishi, M. Nolan, Y. Wang, M. Saito, T. Marwick

    
  • ·Physician-led conscious sedation for external direct current cardioversion for atrial arrhythmia

    Page :S355

    T. Naguib Badie, J. Xu, D. Taylor, H. Kachwalla, L. Thomas, R. Rajaratnum, S. Lo, C. Juergens, D. Leung

    
  • ·Presence of left ventricular non-compaction in hypertrophic cardiomyopathy is associated with arrhythmia

    Page :S356

    L. Lin, P. Choudhary, C. Hsu, S. Grieve, D. Richmond, C. Medi, D. Celermajer, C. Semsarian, R. Puranik

    
  • ·Prevalence of low grade aortic regurgitation in hypertensive subjects

    Page :S356

    R. Reyaldeen, A. Ng, W. Wang

    
  • ·Prognostic value of multislice computed tomography coronary angiography (CTCA) in cardiac transplant vasculopathy

    Page :S356

    C. Yu, P. Macdonald, A. Keogh, C. Hayward, E. Kotlyar, B. Milner, D. Boshell, J. Otton, J. McCrohon, N. Sammel, M. Feneley, A. Jabbour

    
  • ·Quantification of trans-pulmonary physiology in ‘athlete’ population – a validation study of novel echocardiographic parameter “ePLAR”

    Page :S357

    A. Kwon, I. Scalia, G. Scalia

    
  • ·Quantification of trans-pulmonary physiology in patients with small, restrictive ventricular septal defects using the novel echocardiographic parameter, “ePLAR”

    Page :S357

    A. Kwon, I. Scalia, G. Scalia

    
  • ·Quantitative aortography vs cardiac MRI in the assessment of aortic regurgitation

    Page :S358

    A. Ihdayhid, G. Yong, J. Louw, A. Abraham, C. Schultz

    
  • ·Radiation dose and contrast use for diagnostic coronary angiography

    Page :S358

    M. Dooris

    
  • ·Reduced myocardial perfusion in renal transplant patients is not associated with aortic stiffness

    Page :S359

    S. Parnham, J. Gleadle, S. Grover, C. Bradbrook, R. Woodman, C. De Pasquale, J. Selvanayagam

    
  • ·Regression of aorta atherosclerosis in resistant hypertensive patients receiving catheter-based renal artery denervation: serial volumetric computed tomography analysis

    Page :S359

    J. Andrews, Y. Kataoka, A. Pisaniello, J. Montarello, C. Tsioufis, M. Worthley, V. Papademetriou, S. Nicholls, S. Worthley

    
  • ·Rest and stress transluminal attenuation gradient and contrast opacification difference for detection of haemodynamically significant stenoses in patients with suspected coronary artery disease

    Page :S360

    B. Ko, S. Seneviratne, J. Cameron, S. Gutman, M. Crossett, K. Munnar, I. Meredith, D. Wong

    
  • ·Rethinking the role of transoesophageal echocardiography prior to direct current cardioversion in atrial fibrillation

    Page :S360

    B. Pathik, B. Raman, W. Heddle

    
  • ·Right precordial T-wave inversion in healthy endurance athletes can be explained by lateral displacement of the cardiac apex

    Page :S361

    M. Brosnan, G. Claessen, H. Heidbuchel, D. Prior, A. La Gerche

    
  • ·RV S’ VTI by DTI – a novel measure of right ventricular systolic function

    Page :S361

    B. Rudd, A. Kwon, G. Scalia

    
  • ·Semi-automated three dimensional sizing of the aortic annulus pre trans-catheter aortic valve implantation is superior to both two and manual three dimensional sizing

    Page :S362

    R. Perry, J. Judd, R. Prakash, T. Hecker, A. Sinhal, M. Joseph

    
  • ·Short-term effects of transcatheter aortic valve implantation on left ventricular transmural mechanics using multi-layer speckle tracking echocardiography

    Page :S362

    A. Yamada, M. Ischenko, D. Walters, C. Hamilton-Craig, D. Platts, V. Speranza, A. Benjamin, M. Harten, D. Burstow, J. Chan

    
  • ·Speckle strain is more sensitive than LVEF to detect reduced LV systolic function one week post anthracycline chemotherapy for breast cancer

    Page :S363

    P. Stoodley, A. Boyd, K. Vo, D. Richards, R. Hui, P. Harnett, L. Thomas

    
  • ·Strain Analysis using CMR tissue tracking

    Page :S363

    J. Tantiongco, S. Grover, R. Perry, S. Kim, J. Selvanayagam

    
  • ·Subclinical left ventricular dysfunction and 10-year outcomes in type 2 diabetes mellitus

    Page :S364

    D. Holland, T. Marwick, B. Haluska, R. Leano, M. Hordern, J. Hare, Z. Fang, J. Prins, T. Stanton

    
  • ·Subtle increases in heart size persist into adulthood in growth restricted babies- the cardiovascular risk in young Finns study

    Page :S364

    C. Arnott, M. Skilton, S. Ruohonen, M. Juonala, J. Viikari, M. Kahonen, T. Lehtimaki, T. Laitinen, D. Celermajer, O. Raitakari

    
  • ·The continuous spectrum of change in “athletes’ heart”

    Page :S365

    R. Perry, C. De Pasquale, J. Selvanayagam, M. Joseph

    
  • ·The effect of Valsalva manouevre on left atrial and left ventricular filling in patients with hiatal hernia

    Page :S365

    C. Naoum, L. Kritharides, S. Gnanenthiran, D. Hanzek, Z. Pogrebizhsky, D. Martin, G. Falk, J. Yiannikas

    
  • ·The effectiveness of protocol-driven heart rate control with metoprolol and/or ivabradine in achieving optimal heart rate for outpatient CT coronary angiography

    Page :S366

    J. Morton, M. Brown, I. Liddle, J. Economos

    
  • ·The embryological relevance of a double orifice mitral valve, left ventricular noncompaction and myocardial bridging

    Page :S366

    J. Robinson, T. Stanton, J. Moolman, J. Neill

    
  • ·The intracardiac shunt of unknown cause – a case for CMR

    Page :S366

    A. Pisaniello, N. Montarello, P. King, K. Williams, P. Steele, K. Teo

    
  • ·The role of Extracellular matrix in calcium modulation in cardiac trabeculae

    Page :S367

    S. Kaur, M. Ward

    
  • ·The utility of low dose serial computed tomography coronary angiography (CTCA) in the management of spontaneous coronary artery dissection (SCAD)

    Page :S367

    R. Grover, J. Huang, B. Gunalingam, J. McCrohon

    
  • ·The utility of mitral valve index in the detection of prosthetic mitral valve dysfunction

    Page :S368

    S. Luis, L. Blauwet, R. Mehta, H. Samardhi, C. West, C. Luis, G. Scalia, F. Miller, D. Burstow

    
  • ·The utility of Technitium-99m-labelled 3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) scintigraphy in the diagnosis of cardiac amyloidosis: an Australian experience

    Page :S368

    P. Moore, E. Mackenzie, P. Law, D. Korczyk, P. Mollee

    
  • ·Three-dimensional speckle tracking analysis of left ventricular multi-directional strain in severe aortic stenosis with preserved ejection fraction

    Page :S369

    A. Yamada, M. Ischenko, D. Walters, C. Hamilton-Craig, D. Platts, V. Speranza, A. Benjamin, M. Harten, D. Burstow, J. Chan

    
  • ·Use of computed tomographic coronary angiography after equivocal stress tests

    Page :S369

    J. Liu, J. Vazirani, E. Lui, S. Heinze, P. Einsiedel, F. Langenberg, N. Better, S. Joshi

    
  • ·Utilisation of three-dimensional echocardiographic, semi-automated, left ventricular ejection fraction quantification by cardiac nurses: a comparison to cardiac magnetic resonance imaging

    Page :S369

    K. Guppy-Coles, S. Prasad, S. Hillier, K. Smith, N. Biswas, A. Lo, A. Dahiya, J. Atherton

    
  • ·Validation of aortic valve closure timing by EchoPAC Automated Function Imaging algorithm: A comparison to conventional pulsed wave Doppler assessment

    Page :S370

    N. Kelly, M. Harten, A. Tucker, D. Burstow, J. Chan

    
  • ·Would adding two left atrial piloted images to a cardiac magnetic resonance protocol enable rapid, accurate calculation of left atrial volume (LAV)? Use of 320-slice cardiac computed tomography (320-CTCA) as proof of concept

    Page :S370

    N. Nerlekar, T. Barton, P. Mottram, S. Moir

    
  • ·Effect of cardiac output measurement error in the calculation and interpretation of cardiac output-derived haemodynamic variables in the cardiac catheterisation laboratory

    Page :S371

    J. Boland, G. Gazibarich, L. Wang, D. Muller

    
  • ·Quality and safety of cardiac device management in the Northern Territory

    Page :S371

    D. Jewell, M. Ilton, C. Farquharson, N. Kangaharan

    
  • ·Use of ultrasound to assess sternal stability in conventional and adhesive-enhanced sternal closure: a case study

    Page :S372

    D. El-Ansary, A. Royse, L. Denehy, K. King-Shier, P. Fedak

    
  • ·A study of the clinical and organic cardiac predictors of AF symptom severity and quality of life: AF burden but not LV diastolic function predicts severity

    Page :S372

    T. Walters, K. Wick, A. Nisbet, G. Morris, M. Mearns, J. Morton, C. Bryant, P. Kistler, J. Kalman

    
  • ·A study of the psychological predictors of AF severity and quality of life in human AF: personality style is key

    Page :S373

    T. Walters, K. Wick, G. Tan, A. Nisbet, G. Morris, M. Mearns, J. Morton, C. Bryant, P. Kistler, J. Kalman

    
  • ·A superior risk prediction model for in-hospital mortality during acute presentation with pulmonary embolism

    Page :S373

    J. Lau, A. Ng, V. Chow, T. Chung, A. Yong, L. Kritharides

    
  • ·Air versus oxygen in myocardial infarction (AVOID) trial sub-study: time-dependent effect of oxygen administration on myocardial injury

    Page :S374

    D. Stub, K. Smith, S. Bernard, Z. Nehme, M. Stephenson, J. Bray, W. Barger, A. Ellims, A. Taylor, P. Cameron, I. Meredith, D. Kaye

    
  • ·An abstract on the use of new technologies in developing and maintaining Clinical Guidelines

    Page :S374

    M. Branagan, T. Medley, A. Wilson

    
  • ·An article on the role of inpatient coronary angiography in suspected acute coronary syndrome with negative troponin results

    Page :S375

    P. Chandrala, D. Coulshed

    
  • ·Audit on treatment of infective endocarditits in a rural hospital

    Page :S375

    A. Dashwood, A. Fu, S. Stangoni

    
  • ·Australian treatment patterns in atrial fibrillation: results from the global anticoagulation in the field (GARFIELD) registry

    Page :S375

    H. Gibbs, A. Kakkar

    
  • ·Autonomic tone and ventricular repolarisation characteristics in renal transplant recipients

    Page :S376

    M. Wong, J. Kalman, E. Pedagogos, N. Toussaint, J. Vohra, P. Sparks, P. Sanders, P. Kistler, K. Halloran, G. Lee, S. Joseph, J. Morton

    
  • ·Bleeding, dyspnoea and discontinuation in a real world ACS cohort treated with ticagrelor

    Page :S376

    S. Harding, S. Fairley, A. Al-Sinan, A. Holley, C. Howard, P. Matsis, A. Aitken, P. Larsen

    
  • ·Cardiac assessment prior to non-cardiac surgery

    Page :S377

    J. Mooney, G. Hillis, V. Lee, E. Khan, R. Halliwell, M. Vicaretti, C. Moncrieff, C. Chow

    
  • ·Cardiac Haemangioma: a contemporary review of 152 tumours published between 1996-2014

    Page :S377

    A. Dettrick, K. Lau

    
  • ·Cardioprotective drugs dispensed after admission for myocardial infarction (MI) in a whole population cohort: Western Australian Medication Adherence and Costs in Heart disease study (WAMACH)

    Page :S377

    A. Gunnell, L. Nedkoff, J. Hung, M. Knuiman, M. Gillies, M. Ortiz, J. Rankin, E. Geelhoed, M. Hobbs, J. Katzenellenbogen, T. Briffa, F. Sanfilippo

    
  • ·Clinical Outcomes of Atrial Fibrillation (AF) and Anticoagulation within the Dialysis Cohort

    Page :S378

    J. Sajeev, L. Roberts, S. Teh, F. Ha, S. Zargarbashi, J. Carnes, J. Ramzy, M. Street, G. New, M. Freeman, A. Teh

    
  • ·Comparison of recruitment strategies for primary prevention trials: liking social media

    Page :S378

    F. Pathan, K. Whitmore, T. Marwick

    
  • ·Contemporary outcomes of unexpected in hospital cardiac arrest

    Page :S379

    A. Jadeer, K. Chen, R. Tan

    
  • ·Contemporary percutaneous coronary intervention practice in Australia: Assessment of acute myocardial infarction performance measures

    Page :S379

    R. Tavella, A. Brennan, D. Dinh, D. Chew, M. Arstall, M. Worthley, C. Zeitz, J. Beltrame, C. Reid, J. Lefkovits

    
  • ·Contemporary percutaneous coronary intervention practice: assessment of procedure complications

    Page :S380

    R. Tavella, M. Worthley, M. Arstall, D. Chew, C. Zeitz, J. Beltrame

    
  • ·Delta change analysis of troponin T for the diagnosis of AMI

    Page :S380

    P. Tideman, R. Tirimacco, P. Simpson, P. Cowley, L. Siew, N. Berry

    
  • ·Does SNAPSHOT acute coronary syndrome (ACS) represent the national pattern for hospitalisation in 2012?

    Page :S381

    K. Hyun, T. Briffa, K. Nallaiah, D. Brieger, D. Chew, C. Hammett, J. French, B. Carr, T. Howell, J. Redfern

    
  • ·Early results following transcatheter aortic valve implantation with a repositionable self-expanding bioprosthesis

    Page :S381

    I. Meredith, A. Walton, S. Brecker, S. Pasupati, D. Blackman, G. Manoharan

    
  • ·Factors associated with pulseless electrical activity out of hospital cardiac arrest

    Page :S382

    M. Wolbinski, A. Swain, M. Webber, S. Harding, P. Larsen

    
  • ·Frailty in Acute Cardiology: Comparison of a quick clinical assessment against a validated frailty assessment tool

    Page :S382

    T. Hii, J. Lainchbury, P. Bridgman

    
  • ·High prevalence of suicidal ideation in AF: influence of psychology, AF symptom severity and AF burden

    Page :S382

    T. Walters, K. Wick, A. Nisbet, G. Morris, J. Morton, C. Bryant, P. Kistler, J. Kalman

    
  • ·Hospital post-resuscitative performance is associated with clinical outcomes after out-of-hospital cardiac arrest

    Page :S383

    D. Stub, R. Schmicker, M. Anderson, C. Callaway, M. Daya, M. Sayre, J. Elmer, B. Grunau, T. Aufderheide, S. Lin, J. Buick, D. Zive, E. Peterson, G. Nichol

    
  • ·Impact of polypill based therapy on SBP and LDL cholesterol control stratified by potency of baseline regimen

    Page :S383

    R. Webster, A. Patel, S. Thom, V. Selak, C. Bullen, S. Stepien, A. Rodgers

    
  • ·Improving evidence-based medicines prescription in heart failure (HF) and acute coronary syndrome (ACS) at hospital discharge

    Page :S384

    A. Bennett, K. Kerr, G. Sharratt

    
  • ·Infective endocarditis complicated by a Gerbode shunt

    Page :S384

    A. Davies, P. Seah, B. Bastian

    
  • ·INTegrated Electronic General practice support tool, phaRmacy led intervention And combination Therapy Evaluation trial (INTEGRATE)

    Page :S385

    R. Joshi, A. Patel, D. Peiris, B. Saini, T. Usherwood, C. Armor, R. Webster, S. Lo, A. Rodgers, T. Laba, S. Jan, C. Reid, I. Krass, C. Hespe

    
  • ·Index

    Page :S385

    
  • ·Long term prevalence and follow up of atrial fibrillation in chronic kidney disease

    Page :S385

    M. Wong, J. Kalman, E. Pedagogos, N. Toussaint, J. Vohra, P. Sparks, P. Sanders, P. Kistler, K. Halloran, G. Lee, S. Joseph, J. Morton

    
  • ·Long-term follow up of arrhythmic events in chronic kidney disease

    Page :S386

    M. Wong, J. Kalman, E. Pedagogos, N. Toussaint, J. Vohra, P. Sparks, P. Sanders, P. Kistler, K. Halloran, G. Lee, S. Joseph, J. Morton

    
  • ·Management and outcomes of NSTEMI patients with TIMI score 1-3 at Waikato Hospital

    Page :S386

    K. Sree Raman, S. Lam, S. Pasupati

    
  • ·Myocardial tissue characterisation by Cardiovascular Magnetic Resonance diagnoses and tracks recovery after cardiac transplant rejection

    Page :S386

    M. Imran, L. Wang, C. Holloway, J. Otton, C. Yu, J. Huang, K. Moffat, J. Ross, E. Kotlyar, A. Keogh, C. Hayward, P. MacDonald, A. Jabbour

    
  • ·Outcomes in pulmonary arterial hypertension patients with systemic right ventricular pressure

    Page :S387

    C. Arnott, C. Boehm, E. Lau, D. Celermajer

    
  • ·Paradoxical coronary embolism and right to left shunting

    Page :S387

    S. Hayman, M. Dooris

    
  • ·Peripartum takotsubo cardiomyopathy

    Page :S388

    A. Kucia, M. Arstall, G. Dekker

    
  • ·Persistent psychological distress and mortality in patients with stable coronary artery disease in the LIPID trial

    Page :S388

    R. Stewart, D. Colquhoun, S. Marshner, J. Simes, J. Sathananthan, A. Kirby, P. Nestel, N. Glozier, A. O’Neil, B. Oldenburg, A. Tonkin, H. White

    
  • ·Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers

    Page :S389

    J. Sweeting, J. Ingles, K. Ball, C. Semsarian

    
  • ·PoCT troponin - is it safe?

    Page :S389

    P. Tideman, R. Tirimacco, P. Simpson, P. Cowley, M. Siew, N. Berry

    
  • ·Poor adherence to anticoagulant therapy: a call to screen and treat depression in patients with atrial fibrillation

    Page :S389

    D. Colquhoun, N. Malawaraarachchi, A. Ferreira-Jardim

    
  • ·Pressure tracings in constrictive heart disease

    Page :S390

    R. Kurup, C. Hsu, L. Davis

    
  • ·Prevalence and management of vascular disease in Australian patients undergoing non-cardiac surgery

    Page :S390

    J. Mooney, G. Hillis, V. Lee, E. Khan, R. Halliwell, M. Vicaretti, C. Moncrieff, C. Chow

    
  • ·Profile of infective endocarditis in a peripheral Australian Hospital

    Page :S391

    K. Bhuiyan, C. McDonald, A. Karmakar, J. Ahmed, J.F. Sedgwick

    
  • ·Quality measures of timely and effective early care for acute STEMI patients in Victorian regional hospitals: The VCOR Early STEMI Management Registry

    Page :S391

    J. Lefkovits, A. Brennan, D. Dinh, A. Wright, T. Chan, B. Forge, H. Connor, J. Dennett, T. Young, R. Krones, T. Ibrahim, C. Reid

    
  • ·Recurrence of atrial fibrillation after electrical cardioversion is not predicted by electrocardiographic P wave duration or PR interval

    Page :S392

    A. Challa, N. Bhadange, M. Habibian, M. Zhang, S. Buchholz

    
  • ·Screening the asymptomatic systolic murmur. An audit of two New Zealand Centres

    Page :S392

    T. Pasley, J. Pemberton, G. Porter, M. Wheeler

    
  • ·ST segment elevation due to Brugada pattern induced by hyperkalaemia during diabetic ketoacidosis

    Page :S393

    S. Arunothayaraj, S. Peters, J. Kalman

    
  • ·Subspecialisation in cardiology care and outcome: Should clinical services be redesigned, again?

    Page :S393

    B. Pathik, C. De Pasquale, A. McGavigan, A. Sinhal, J. Vaile, P. Tideman, D. Jones, C. Bridgman, J. Selvanayagam, W. Heddle, D. Chew

    
  • ·Supine Ergometry Echocardiography is a safe diagnostic tool in risk stratification of moderate to severe valvular heart disease

    Page :S394

    R. Davis, N. Hurst, D. Foster, H. Kandy, J. Lim, S. Mylabathula

    
  • ·The adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation

    Page :S394

    D. Baker, B. Wilsmore, S. Narasimhan

    
  • ·The association between condition-specific streaming and outcomes in modern cardiovascular care

    Page :S395

    C. O'Shea, D. Chew, D. Balakrishnan, M. Horsfall, A. McGavigan, C. De Pasquale, P. Tideman, P. Aylward, B. Moyes

    
  • ·The effect of basiliximab induction post cardiac transplantation on renal function and acute allograft rejection

    Page :S395

    J. Gan, W. Chan, G. Grima, A. Munns, G. Javorsky

    
  • ·The effect of OSA on post infarction left ventricular function and scar size

    Page :S396

    J. Xiong, T. Nguyen, L. Hee, U. Premawardhana, R. Rajaratnam, C. Juergens, J. French, D. Richards, L. Thomas, H. Dimitri

    
  • ·The incremental role of ePLAR (echocardiographic pulmonary to left atrial ratio) in the diagnosis of sub-massive acute pulmonary emboli

    Page :S396

    G. Scalia, J. Hunter, I. Scalia, D. Wong, B. Fitzgerald, D. Burstow, A. Riha, D. Platts

    
  • ·The prevalence and incidence of Atrial Fibrillation (AF) in patients with acute Pulmonary Embolism (PE)

    Page :S397

    D. Adikari, D. Yuan, J. Lau, V. Chow, T. Chung, A. Yong, L. Kritharides, A. Ng

    
  • ·What is the cause of the guideline prescribing gap post myocardial infarction?

    Page :S397

    B. Wilkins, S. Hullikunte, M. Simmonds, S. Harding, P. Larsen

    
  • ·Women with atrial fibrillation have greater stroke rates than men on Warfarin: Narrowing the gender gap on NOACs

    Page :S398

    D. Colquhoun, D. Cross, D. Yates, J. Amerena

    
  • ·A case of Brugada syndrome in a patient with a negative flecainide challenge

    Page :S398

    F. Lee, J. Ng

    
  • ·A case report on sudden cardiac death, Ebstein's anomaly and Left ventricular noncompaction

    Page :S399

    M. McGee, N. Collins

    
  • ·Analysis of temporal and spatial variability of spontaneous type 1 brugada ECG: correlation with symptoms and sudden cardiac death events

    Page :S399

    B. Gray, C. Semsarian, B. Freedman, C. Medi, R. Sy

    
  • ·Androgen augmentation of ischaemia-induced neovascularisation is dependent on the genomic action of the androgen receptor

    Page :S400

    Y. Lam, L. Leece, D. Handelsman, M. Ng

    
  • ·Confounder bias in sudden death risk stratification for hypertrophic cardiomyopathy

    Page :S400

    J. Ingles, C. Medi, C. Burns, L. McCormack, L. Yeates, L. Hunt, J. McGaughran, K. McGeechan, J. Atherton, T. Driscoll, C. Semsarian

    
  • ·Dysregulation of c-kit expression parallels the development of spontaneous genetic cardiac hypertrophy

    Page :S401

    F. Marques, P. Prestes, P. Lewandowski, S. Harrap, F. Charchar

    
  • ·Early growth response-1 functions as a master regulator of remote hypoxic preconditioning

    Page :S401

    M. Billah, H. Mudaliar, S. Hunyor, R. Bhindi

    
  • ·Evidence for altered post-transcriptional regulation of TGF-? signaling in Marfan syndrome

    Page :S401

    E. Robertson, Y. Lu, D. Lai, M. Kekic, B. Hambly, R. Jeremy

    
  • ·Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrest

    Page :S402

    L. Lam, J. Ingles, C. Turner, M. Kilborn, R. Bagnall, C. Semsarian

    
  • ·Inter-observer variability in classification of early repolarisation

    Page :S402

    J. Lipton, E. Hodkinson, P. Kabunga, R. Sy, C. Semsarian, C. Medi

    
  • ·Marfan's syndrome presenting as an ascending aortic dissection : A Case Study

    Page :S403

    R. Kurup, D. Ross

    
  • ·Navigating uncharted waters: novel echocardiography techniques for non-invasive in-vivo assessment of contractile function in adult zebrafish and its potential applications for research in cardiovascular genetics

    Page :S403

    L. Wang, S. Kesteven, M. Imtiaz, I. Martin, M. Feneley, D. Fatkin

    
  • ·Potential role of multiple mutations altering thoracic aortic aneurysm formation

    Page :S403

    E. Robertson, Y. Lu, M. Kekic, B. Hambly, R. Jeremy

    
  • ·Prevalence of early repolarisation in unaffected family members of patients with genetic heart disease

    Page :S404

    E. Hodkinson, P. Kabunga, J. Lipton, R. Sy, C. Semsarian, C. Medi

    
  • ·Prevalence of early repolarisation pattern in patients with inherited channelopathy

    Page :S404

    P. Kabunga, J. Lipton, E. Hodkinson, R. Sy, C. Semsarian, C. Medi

    
  • ·Prolonged ECG monitoring unmasks a high prevalence of spontaneous type 1 changes in “drug-induced” Brugada syndrome

    Page :S405

    B. Gray, C. Semsarian, B. Freedman, C. Medi, R. Sy

    
  • ·Right ventricular function in Marfan syndrome

    Page :S405

    R. Jeremy, M. Van den Dorpel, F. Loeper

    
  • ·Sudden cardiac death from genetic heart disease: psychological impact to the surviving at-risk family members

    Page :S406

    J. Ingles, C. Spinks, L. Yeates, N. Kasparian, C. Semsarian

    
  • ·The Cardiac Genetics Clinic – a model for multidisciplinary genomic medicine

    Page :S406

    D. Zentner, T. Thompson, P. James, A. Trainer, L. Ades, I. Macciocca, J. Taylor, K. Mann, M. Bogwitz, A. Aggarwal, N. Lewis, N. Morgan, J. Vohra, I. Winship

    
  • ·The genetic heart disease patient day: Improving education and patient understanding

    Page :S407

    L. Yeates, T. Sarina, C. Burns, C. Spinks, R. Bagnall, L. Lam, J. Sweeting, C. Cutmore, T. Tsoutsman, B. Gray, C. Medi, J. Ingles, C. Semsarian

    
  • ·Ventricular-vascular coupling in Marfan syndrome and familial aortic aneurysm

    Page :S407

    R. Jeremy, F. Loeper, J. Oosterhuis, M. Van Den Dorpel

    
  • ·A meta-analysis of endoscopic versus conventional open radial artery harvesting for coronary artery bypass graft surgery

    Page :S408

    C. Cao, D. Tian, S. Ang, S. Virk, E. Novis, C. Wilcox, T. Yan

    
  • ·A meta-analysis of robotic versus conventional mitral valve surgery

    Page :S408

    C. Cao, S. Virk, E. Novis, C. Wilcox, T. Yan

    
  • ·Aortic stenosis in Australia: disease prevalence and patient eligibility for aortic valve replacement

    Page :S409

    P. De Sciscio, J. Brubert, M. De Sciscio

    
  • ·Aortic valve replacement with or without coronary artery bypass grafting: stroke outcomes and predictors

    Page :S409

    T. Wang, T. Ramanathan, D. Choi, P. Ruygrok

    
  • ·Assessing metabolic and functional performance of human donor hearts: Possible application for donation after circulatory death

    Page :S409

    P. Bhaskaran, F. Rosenfeldt, R. Ou, S. Marasco, I. Buttfield, J. Woodard, S. Perera, D. McGiffin

    
  • ·Association between patterns of aortic dilatation and aortic pathology in consecutive aortic surgery cases

    Page :S410

    A. Hardikar, R. Harle, T. Marwick

    
  • ·Atrial fibrillation following cardiac surgery leads to an increased length of stay

    Page :S410

    J. Bloom, A. Voskoboinik, J. Shaw

    
  • ·Blunt chest trauma resulting in flail anterior tricuspid leaflet: a case report

    Page :S411

    M. Sharma, M. Eskandari

    
  • ·Cardiovascular outcome following mitral valve annuloplasty band removal following foreign body reaction, recurrent valve thrombosis and thromboembolic stroke. Possible implications for future practice

    Page :S411

    S. Lovibond, C. Hengel, M. Rowland

    
  • ·Does annual site-specific caseload influence valve surgical outcome in Australia?

    Page :S412

    E.A. Russell, G. Maguire, L. Tran, C. Reid, W. Walsh, A. Brown, R. Baker, R. Tam, J. Bennetts

    
  • ·Dynamic, multi-planar motion of the sternum following median sternotomy and sternal instability

    Page :S412

    D. El-Ansary, G. Waddington, R. Adams

    
  • ·Eight-year cohort study of octogenarians undergoing aortic valve replacement with or without concurrent coronary artery bypass grafting

    Page :S413

    T. Wang, D. Choi, T. Ramanathan, P. Ruygrok

    
  • ·Ensuring quality data in clinical registries - audit results of the ANZSCTS database program between 2011 - 2014

    Page :S413

    L. Tran, N. Marrow, C. Ayres, D. Dahya, G. Shardey, J. Smith, C. Reid

    
  • ·Impact of comorbidities and gender on the use of coronary interventions in patients with high-risk non-ST-segment elevation acute coronary syndrome

    Page :S414

    L. Worrall-Carter, S. McEvedy, A. Wilson, M. Rahman

    
  • ·Mitral Valve Repair (MVR) failure presenting as haemolytic anaemia

    Page :S414

    A. Khan, A. Ashraf, A. Levendel

    
  • ·Index

    Page :S415

    
  • ·Physical examination of the sternum following cardiac surgery: validity and reliability of a Sternal Instability Scale (SIS)

    Page :S415

    D. El-Ansary, G. Waddington, L. Denehy, R. Adams

    
  • ·Prognostic utility of risk scores at predicting mortality and morbidity after combined aortic valve replacement and coronary artery bypass grafting

    Page :S415

    T. Wang, D. Choi, G. Gamble, T. Ramanathan, P. Ruygrok

    
  • ·Prognostic value of post-operative aspartate aminotransferase levels after isolated coronary artery bypass grafting and isolated isolated aortic valve replacement

    Page :S416

    T. Wang, R. Stewart, G. Gamble, T. Ramanathan, H. White

    
  • ·Relationship between beta-blockers and mortality in diabetic patients undergoing coronary artery bypass grafting

    Page :S416

    T. Wang, A. Woodhead, J. Pemberton, T. Ramanathan

    
  • ·Surgical relief of left ventricular outflow tract obstruction in adults with congenital aortic stenosis and associated aortic annulus hypoplasia and/or subaortic obstruction

    Page :S416

    P. Skillington, M. Larobina, L. Grigg, L. Balding, D. Zentner, W. Wilson

    
  • ·Utility of high-sensitivity troponins after combined aortic valve replacement and coronary artery bypass grafting towards defining myocardial infarction

    Page :S417

    T. Wang, R. Stewart, D. Choi, S. Harrmos, G. Gamble, T. Ramanathan, H. White

    
  • ·Validation of 30-day mortality data in the ANZSCTS database through successful linkage with the national death index database

    Page :S417

    L. Tran, C. Ayres, N. Marrow, D. Dahya, G. Shardey, C. Reid

    
  • ·A family-based education program for heart failure patients and carers in rural Thailand: a randomised controlled trial

    Page :S418

    N. Srisuk, J. Cameron, C.F. Ski, D.R. Thompson

    
  • ·An evaluation of peripheral vascular access site complications following cardiac angiography and percutaneous coronary intervention (PCI)

    Page :S418

    J. Parkinson, T. Buckley, J. Gullick, A. Marshall, D. Alchin

    
  • ·Care-seeking decisions for worsening symptoms in Heart Failure: a qualitative metasynthesis

    Page :S419

    S. Ivynian, M. DiGiacomo, S. Jha, C. Crossley, P. Newton

    
  • ·Inappropriate use of continuous cardiac telemetry and its potential adverse impact on human resources management and financial burdens

    Page :S419

    M. Habibian, K. Crane, V. Beattie, M. Bazley, M. Zhang, S. Buchholz

    
  • ·Index

    Page :S419

    
  • ·Psychometric testing of the Heart Failure Screening Tool (Heart-FaST)

    Page :S420

    J. Cameron, T. Habota, C. Ski, S. McLennan, P. Rendell, D. Thompson

    
  • ·The first forty-eight hours post Transcatheter Aortic Valve Implantation: Nursing Management of temporary pacing wire

    Page :S420

    S. Oxley, S. Lewis, L. Bell, R. Dick, A. Walton

    
  • ·Two-hour recovery time after coronary angiogram via trans-radial and trans-femoral approach with closure device - safe & feasible

    Page :S420

    M. De Raya, R. Naidu, J. Holden, D. Taylor

    
  • ·A complete anatomical model of vascular network growth during childhood

    Page :S421

    P. Kunniardy, J. Mynard

    
  • ·A dedicated Adult Congenital Heart Disease (ACHD) Database - the first 4000 patients

    Page :S421

    D. Jackson, P. Bannon, R. Cordina, G. Sholler, D. Celermajer

    
  • ·A model for early transient pressure overload to simulate successful early repair of aortic coarctation

    Page :S422

    A. Krishnan, D. Drak, C. Canniffe, W. Stanley, S. Bao, D. Celermajer, J. Liu

    
  • ·A new look at bronchopulmonary dysplasia: Role of systemic vascular & cardiac function in therapeutic options

    Page :S422

    A. Sehgal, A. Malikiwi, K. Tan, S. Menahem

    
  • ·Abnormal cardiac Wnt signalling in preterm and near-term fetal lambs with sustained in utero stress

    Page :S423

    N. Gupta, R. Krauss, M. Cheung, J. Smolich, S. Pepe

    
  • ·Accuracy of focussed cardiac ultrasound screening for rheumatic heart disease by health workers with limited training

    Page :S423

    D. Engelman, J. Kado, B. Remenyi, S. Colquhoun, J. Carapetis, N. Wilson, S. Donath, A. Steer

    
  • ·An exploration of the health outcomes of children who have undergone a cardiac procedure in the first year of life

    Page :S424

    C. Lawley, S. Lain, C. Algert, G. Sholler, D. Winlaw, C. Roberts, G. Figtree

    
  • ·Antenatal diagnosis, associations and outcomes of vascular rings

    Page :S424

    M. Henry, T. Robertson

    
  • ·Antenatal betamethasone regulates microRNA-335* expression in ovine fetal heart, lungs and placenta

    Page :S425

    R. Krauss, N. Gupta, M. Cheung, J. Smolich, S. Pepe

    
  • ·Aortic impedance mismatching correlates with systolic and pulse pressures late after aortic coarctation repair

    Page :S425

    J. Mynard, G. Cahoon, M. Lee, N. Wo, R. Kowalski, J. Smolich, Y. D’Udekem, M. Cheung

    
  • ·Aortic reoperation in adults with corrected Conotruncal defects

    Page :S426

    M. Larobina, N. Keenan, R. Wynne, D. Zentner, P. Naidu, W. Wilson, L. Balding, L. Grigg, P. Skillington

    
  • ·Aortic valve cusp prolapse with severe aortic regurgitation secondary to perimembranous ventricular septal defect - the Laubry-Pezzi syndrome

    Page :S426

    S. Arunothayaraj, H. Adams, P. Arunothayaraj, A. MacIsaac

    
  • ·Cardiac CT in patients with single ventricle physiology

    Page :S427

    S. Biswas, K. O’Donnell, E. Lui, W. Wilson, F. Langenberg, S. Heinze, N. Better, M. Cheung, L. Grigg, S. Joshi

    
  • ·Cardiac pregnancy clinic - a new clinical service at the Royal Melbourne Hospital

    Page :S427

    D. Zentner, E. Posma, L. Balding, L. Grigg

    
  • ·Comparative outcomes after acute aortic dissection in genetic aortopathy syndromes

    Page :S427

    D. van der Linde, L. Davies, A. Sherrah, P. Bannon, M. Vallely, M. Wilson, L. Turner, A. Keech, R. Jeremy

    
  • ·Comparison of surgical repair and percutaneous stent implantation for native coarctation of the aorta in patients >15 years of age

    Page :S428

    X. Yeaw, D. Murdoch, V. Wijesekera, J. Sedgwick, O. Raffel, D. Walters

    
  • ·Dilated cardiomyopathy in a Saudi male infant with Vici syndrome

    Page :S428

    R. Waggass

    
  • ·Effects of Siemens Artis Q.zen on radiation dose on patent ductus arteriosus closure: A single centre experience

    Page :S429

    B. Anderson, S. Lee, D. Vuong, R. Justo, C. Ward

    
  • ·Electrophysiology and radiofrequency ablation for the management of tachyarrhythmias in adult Fontan patients

    Page :S429

    K. Francis, M. McGuire, D. Celermajer

    
  • ·Establishing a neurodevelopmental follow up program for neonates with complex congenital heart disease and ECLS survivors - our first year experience

    Page :S429

    K. Eagleson, C. Stocker, R. Smith, R. Justo

    
  • ·Extra cardiac conduit Fontan circulation - outcomes in the first adult cohort

    Page :S430

    C. Cheshire, D. Zentner, L. Grigg

    
  • ·Fertility and pregnancy in the Fontan population

    Page :S430

    D. Zentner, A. Kotevski, I. King, L. Grigg, Y. d’Udekem

    
  • ·Haemodynamic performance of the Medtronic Freestyle porcine bioprosthesis in the pulmonary position in adult patients with corrected Tetralogy of Fallot

    Page :S431

    M. Larobina, N. Keenan, R. Wynne, D. Zentner, P. Naidu, W. Wilson, L. Balding, L. Grigg, P. Skillington

    
  • ·Hampton's hump in a patient with PDA endocarditis

    Page :S431

    T. Ford, J. Roy, D. Rees

    
  • ·Health-related quality of life and disease impact in complex congenital heart disease and ECLS survivors - ongoing follow up assessment

    Page :S431

    K. Eagleson

    
  • ·Increased left ventricular stroke volume in children and adults with repaired Tetralogy of Fallot (rTOF) and moderate-severe right ventricular dilatation

    Page :S432

    G. Gnanappa, D. Celermajer, S. O’Meagher, R. Puranik, J. Ayer

    
  • ·Late clinical outcomes post transcatheter intervention for coarctation

    Page :S432

    W. Wilson, A. Shah, L. Benson, M. Osten, E. Horlick

    
  • ·Left ventricular function as a predictor for long-term outcomes in Marfan syndrome

    Page :S433

    D. van der Linde, F. Loeper, P. Bannon, M. Vallely, M. Wilson, R. Jeremy

    
  • ·Long term outcomes in double inlet left ventricle and tricuspid atresia with transposed great vessels

    Page :S433

    D. Winlaw, L. Franken, M. Admiraal, J. Ayer, A. Iyengar, A. Cole, C. Verrall, C. Brizard, G. Sholler, Y. D’Udekem

    
  • ·Mortality in adults with congenital heart disease - Why do they die?

    Page :S434

    P. Naidu, L. Grigg, D. Zentner

    
  • ·Older age is associated with reduced Pulmonary regurgitation in repaired Tetralogy of Fallot with mild to moderate right ventricular dilatation

    Page :S434

    G. Gnanappa, D. Celermajer, S. O’Meagher, R. Puranik, J. Ayer

    
  • ·Outcomes for Indigenous children undergoing cardiac surgery

    Page :S435

    E. Justo, B. Reeves, R. Justo, N. Alphonso

    
  • ·Outcomes of adults with Fontan palliation for underlying hypoplastic left heart syndrome

    Page :S435

    W. Wilson, E. Hickey, A. Valente, C. Silversides, E. Oechslin, L. Roche, L. Grigg, E. Teo, L. Burchill, I. Von Der Muhll, J. Grewal, M. Greutmann, K. Hickey, Y. Emmanuel, P. Clift, R. Wald

    
  • ·Percutaneous intervention for severe coarctation with aortic occlusion

    Page :S436

    W. Wilson, R. Gurvitch, L. Eastaugh, L. Grigg

    
  • ·Quality of life of adults with congenital heart disease, a Melbourne cohort analysis

    Page :S436

    S. Eaton, Q. Wang, S. Menahem

    
  • ·Severity of left ventricular hypoplasia is associated with degree of tricuspid regurgitation in infants with hypoplastic left heart syndrome

    Page :S436

    K. Laohachai, G. Sholler, D. Winlaw, J. Ayer

    
  • ·Single coronary artery from the anterior right sinus of Valsalva - an extremely rare coronary anomaly

    Page :S437

    H. Adams, S. Gutman, S. Arunothayaraj, A. Burns, J. Gutman

    
  • ·Sleep disordered breathing in adult patients with tetralogy of Fallot repair

    Page :S437

    A. Bailey, A. Zala, R. Hatton, S. Miles, N. Collins

    
  • ·The juvenile hypoplastic transverse arch - therapeutic dilemma

    Page :S438

    T. Goh

    
  • ·”To be honest, I don’t really care”: what hope is there for Mâori women's heart health?

    Page :S438

    A. Rolleston, C. Lawes, V. Parag, N. Walker, R. Doughty

    
  • ·A case of severe Acute Rheumatic Carditis in an Indigenous Australian boy

    Page :S439

    W. Ahmad, S. Thambar

    
  • ·Acute rheumatic fever and heart block requiring temporary pacing

    Page :S439

    Y. Chacko, P. Gould

    
  • ·Acute rheumatic fever spike in a remote Aboriginal community in the Northern Territory: another challenge to Closing The Gap initiatives

    Page :S439

    B. Remenyi, M. Fittock, K. Hardie, C. Gargan, M. Ilton, N. Kangaharan

    
  • ·Adequacy of treatment and follow up of common cardiac conditions in Indigenous patients in rural and remote Queensland

    Page :S440

    P. Jauncey, S. McKenzie

    
  • ·Baseline comorbidities and in-hospital outcomes of Indigenous Australians undergoing percutaneous coronary intervention

    Page :S440

    J. O’Brien, R. Tavella, N. Andrianopoulos, C. Zeitz, A. Brennan, C. Reid, A. Ajani, D. Clark, J. Beltrame, S. Duffy

    
  • ·Exploring Aboriginal patients’ experiences of cardiac care at a major metropolitan hospital in Melbourne

    Page :S441

    L. Worrall-Carter, K. Daws, M. Rahman, S. Maclean, K. Rowley, S. Andrews, A. MacIsaac, P. Lau, S. McEvedy, J. Willis, K. Arabena

    
  • ·Impact of ethnicity on primary angioplasty (PAMI) outcome : The Waikato experience

    Page :S441

    K. Khokhar, G. Devlin, G. Gamble, A. Nizar, A. Vitta, C. Nunn

    
  • ·Rheumatic heart disease: A costly burden

    Page :S442

    A. Mekhail, P. Singh, A. Aitken, N. Wilson

    
  • ·Safety & efficacy of warfarin therapy within top end NT remote communities

    Page :S442

    J. Dennis, W. Majoni, J. Tinsley, N. Kangaharan

    
  • ·“They never ask, I never ask”: Raising the topic of disease prevention

    Page :S443

    N. Walker, C. Lawes, V. Parag, A. Rolleston, R. Doughty

    
  • ·2-year health related quality-of-life outcomes after percutaneous coronary intervention in elderly patients

    Page :S443

    B. Yan, L. Chan, V. Lee, C. Yu, C. Reid

    
  • ·Are acute coronary syndrome (ACS) patients experiencing an economic burden in Australia?

    Page :S444

    K. Hyun, B. Essue, M. Woodward, D. Brieger, S. Jan, J. Redfern

    
  • ·Cost effective analysis of the risk factor management clinic versus usual care study in patients undergoing AF ablation (ARREST-AF: CENT Study)

    Page :S444

    R. Pathak, M. Evans, M. Middeldorp, A. Mehta, W. Abhayaratna, D. Lau, P. Sanders

    
  • ·Geographical influence on follow-up. Does distance from hospital or socioeconomics have a greater impact on attendance at chest pain clinic?

    Page :S445

    A. Vlachadis Castles, I. Tsay, A. Gan, V. Liang, W. van Gaal

    
  • ·Identifying health literacy levels and modifiable risk factors in adults with cardiovascular disease

    Page :S445

    V. Betihavas, J. Duff, A. Chan, R. Say, C. Ferry, K. Walker

    
  • ·Increasing clinical and economic burden of heart failure among older Australians

    Page :S446

    Y. Chan, J. Ball, T. Teng, C. Tuttle, Y. Ahamed, M. Carrington, P. Scuffham, S. Stewart

    
  • ·Minimisation of medical terminology in secondary care correspondence in patients with chronic health conditions: impact on understanding and patient reported outcomes

    Page :S446

    M. Wernick, P. Hale, N. Anticich, S. Busch, L. Merriman, B. King, T. Pegg

    
  • ·Next generation patient education tools for cardiac disorders

    Page :S447

    P. van Dam, D. Pickham, H. Salisbury, S. Race, E. Ashley

    
  • ·The association of ambient particulate matter with heart failure incidence

    Page :S447

    Q. Huynh, F. Johnston, T. Marwick, K. Negishi

    
  • ·A statewide telephone-based coaching program for reducing cardiovascular risk: the Queensland Health model – time to make it national?

    Page :S448

    M. Vale, C. Ski, G. Bennett, V. Chalmers, K. McFarlane, M. Jelinek, I. Scott, D. Thompson

    
  • ·A systematic review investigating smoking relapse in women hospitalised due to coronary heart disease

    Page :S448

    M. Rahman, K. Edward, L. Montgomery, S. McEvedy, A. Wilson, L. Worrall-Carter

    
  • ·An article on the effect of physiotherapy within a heart failure outreach service on participation in structured exercise training

    Page :S449

    M. King, J. McVeigh, R. Wickham

    
  • ·Index

    Page :S449

    
  • ·Anti-inflammatory effect of colchicine in Japanese patients with stable coronary artery disease: A pilot study

    Page :S449

    T. Yakushiji, M. Ono, W. Igawa, K. Takehiko, S. Ebara, T. Okabe, K. Yamashita, M. Yamamoto, K. Hoshimoto, S. Saito, K. Amemiya, N. Isomura, H. Araki, M. Ochiai

    
  • ·Association between adequacy of long chain omega-3 intake and N-terminal pro brain natriuretic peptide (NT-proBNP) in those at risk of heart failure

    Page :S450

    A. Owen, E. Ashton, H. Krum, C. Reid, D. Liew, U. Boffa, S. Stewart, L. Shiel, R. Wolfe, D. Campbell

    
  • ·Barriers to exercise rehabilitation in the older adult with heart failure

    Page :S450

    C. Giuliano, K. Cowie, J. Saliba, E. Scholes, K. Fisher, N. Cox, C. Neil

    
  • ·Can a smartphone-based secondary prevention program facilitate early mobilisation in patients with acute coronary syndromes?

    Page :S450

    M. Yudi, O. Farouque, M. Jelinek

    
  • ·Can mobile phone text messaging improve medication adherence to long term therapies?

    Page :S451

    J. Thakkar, A. Thiagalingam, C. Chow

    
  • ·Cardiac rehabilitation referral and completion: results from the South Australian minimum dataset for cardiac rehabilitation programs

    Page :S451

    R. Tavella, K. O’Toole, R. Tirimacco, A. Lloyd, K. Pennington, S. Drilling, V. Poulsen, N. Berry, R. Clark, C. Astley, W. Keech

    
  • ·Classification of risk factors for coronary artery disease (CAD) in young patients (=<45 years) with angiographically-proven CAD

    Page :S452

    S. Moloi, A. Doost Hosseiny, S. Atique, A. Farshid

    
  • ·Clinical features associated with referral to cardiac rehabilitation following acute myocardial infarction

    Page :S452

    R. Tavella, M. Arstall, M. Worthley, D. Chew, C. Zeitz, J. Beltrame

    
  • ·Comparison of aerobic interval training and moderate continuous training in patients with coronary artery disease

    Page :S453

    K. Liou, S. Ho, S. Ooi

    
  • ·Country access to cardiac health (CATCH) program: improving rehospitalisation rates and length of stay for cardiac rehabilitation using innovative telehealth delivery

    Page :S453

    P. Tideman, R. Tirimacco, N. Berry, P. Cowley, S. Jones, A. Church, R. Clark

    
  • ·CVD Risk Assessing 90% of a country: the New Zealand experience

    Page :S453

    K. Arcus, G. Devlin

    
  • ·Diet consumption and behaviours of patients with coronary heart disease (CHD) presenting to a tertiary referral hospital in Western Sydney

    Page :S454

    L. de Keizer, J. Redfern, J. Thakkar, A. Thiagalingam, C. Chow

    
  • ·E-health, patient-centred goal-setting and cardiovascular disease

    Page :S454

    A. Wong, L. Neubeck, G. Coorey, J. Mulley, K. Weir, D. Peiris, J. Redfern

    
  • ·Evaluating the quality of internet information for prevention of cardiovascular disease

    Page :S455

    H. Hu

    
  • ·Exposure to parental smoking in childhood is associated with increased risk of carotid atherosclerotic plaque in adulthood: The Cardiovascular Risk in Young Finns Study

    Page :S455

    H. West, M. Juonala, S. Gall, M. Kähönen, T. Laitinen, L. Taittonen, J. Viikari, O. Raitakari, C. Magnussen

    
  • ·High discontinuation rates seen in major anticoagulation trials of Warfarin vs NOACs: A call to action

    Page :S456

    D. Colquhoun, C. Beames, A. Ferreira-Jardim, J. Abel, J. Ham

    
  • ·Important factors for implementing a clinical trial in primary care

    Page :S456

    G. Coorey, J. Mulley, D. Peiris, L. Neubeck, K. Weir, A. Wong, J. Redfern

    
  • ·Improved persistence with non-vitamin K oral anti-coagulants compared to warfarin in patients with atrial fibrillation

    Page :S457

    L. Simons, B. Freedman, M. Ortiz, D. Colquhoun

    
  • ·The association between heart rate variability and fine particulate air pollution: A systematic review of 9593 subjects

    Page :S457

    M. Lankaputhra, R. Kelly, K. Negishi

    
  • ·Timed up and go test: A reliable test in patients with chronic heart failure?

    Page :S458

    R. Hwang, N. Morris, A. Mandrusiak, A. Mudge, J. Suna, J. Adsett, T. Russell

    
  • ·Triggering of acute coronary occlusion by episodes of physical exertion

    Page :S458

    T. Buckley, S. Soo Hoo, J. Fethney, E. Shaw, P. Hansen, G. Tofler

    
  • ·Understanding coronary disease illness beliefs and patients’ activation

    Page :S458

    K. Santo, S. Kirkendall, C. Chow, A. Rich, J. Redfern

    
  • ·Utility and use of technology to access health information among patients with chronic diseases

    Page :S459

    R. Kurup, H. Hu, R. Kurup, A. Thiagalingam, C. Jin-Gun, V. Lee, W. Cheung, M. Roberts, J. Wheatley, C. Chow

    
  • ·Author Index

    Page :S460